Publications from OUS - Dept of Cardiology Ullevaal - Clinical Cardiovascular Research Group

674 publications found

Publications 2025

1. Al Said S, O'Donoghue ML, Ran X, Murphy SA, Atar D, Keech A, Flores-Arredondo JH, Wang B, Sabatine MS, Giugliano RP (2025)
   Long-Term Lipid Lowering With Evolocumab in Older Individuals
   J Am Coll Cardiol, 85 (5), 504-512
   DOI 10.1016/j.jacc.2024.11.019, PubMed 39909681
2. Alexander JH, Lydon EJ, Piccini JP, Viethen T, Oldgren J, Goodman SG, Steffel J, Russo AM, van Gelder IC, Ferdinand KC, Lopes RD, Mundl H, Benczur B, Gómez-Doblas JJ, Glikson M, Goudev A, Grove EL, Halvorsen S, Kiviniemi T, Martin AC, Sandhu RK, Vinereanu D, Rockhold FW, Caso V, Coppolecchia R et al. (2025)
   Asundexian or Apixaban in Patients With Atrial Fibrillation According to Prior Oral Anticoagulant Use: A Subgroup Analysis of the OCEANIC-AF Randomized Clinical Trial
   JAMA Cardiol, 10 (6), 555-563
   DOI 10.1001/jamacardio.2025.0277, PubMed 40136309
3. Andrup S, Eriksen SS (2025)
   Først og fremst ikke skade
   Tidsskr Nor Laegeforen, 145 (7)
   DOI 10.4045/tidsskr.25.0143, PubMed 40474632
4. Araiza-Garaygordobil D, Alexander T, Huber K, Halvorsen S, Ahrens I, Alviar C, Arias-Mendoza A, Dippenaar A, Gorog DA, Campo G, Rakisheva A, Mouine N, Gabulova R, Orlić D, Pereira H, Barbato E, Candiello A, Sobhy M, Piek JJ (2025)
   Reperfusion Therapy for ST Elevation Myocardial Infarction in Low to Middle-Income Countries. A Clinical Consensus Statement of the Association for Acute CardioVascular Care (ACVC), the European Association of Percutaneous Cardiovascular Interventions (EAPCI), the European Association of Preventive Cardiology (EAPC), the ESC Working Group on Thrombosis, and the Stent - Save a Life! Initiative
   Eur Heart J Acute Cardiovasc Care (in press)
   DOI 10.1093/ehjacc/zuaf114, PubMed 40922666
5. Askeland-Gjerde DE, Westlye LT, Andersson P, Korbmacher M, de Lange AM, van der Meer D, Smeland OB, Halvorsen S, Andreassen OA, Gurholt TP (2025)
   Mediation Analyses Link Cardiometabolic Factors and Liver Fat With White Matter Hyperintensities and Cognitive Performance: A UK Biobank Study
   Biol Psychiatry Glob Open Sci, 5 (4), 100488
   DOI 10.1016/j.bpsgos.2025.100488, PubMed 40330223
6. Atar D, Linde C (2025)
   Subclinical atrial fibrillation: Who benefits from oral anticoagulation?
   Kardiol Pol, 83 (7-8), 808-813
   DOI 10.33963/v.phj.106733, PubMed 40512045
7. Atar D, Roffi M (2025)
   Fellow of the European Society of Cardiology: recognizing excellence in cardiology
   Eur Heart J, 46 (24), 2253-2255
   DOI 10.1093/eurheartj/ehaf246, PubMed 40326344
8. Atar D, Vandenbriele C, Agewall S, Gigante B, Goette A, Gorog DA, Holme PA, Krychtiuk KA, Rocca B, Siller-Matula JM, Valgimigli M, Rubboli A, Klamroth R (2025)
   Management of patients with congenital bleeding disorders and cardiac indications for antithrombotic therapy
   Eur Heart J Cardiovasc Pharmacother, 11 (3), 275-289
   DOI 10.1093/ehjcvp/pvaf006, PubMed 40145128
9. Bahlmann E, Gerdts E, Einarsen E, Midtbø H, Pedersen ER, Rossebø A, Willems S, Cramariuc D (2025)
   Impact of sex-specific thresholds for low flow in assessment of prognosis in concordantly and discordantly graded aortic valve stenosis
   Eur Heart J Cardiovasc Imaging, 26 (2), 280-286
   DOI 10.1093/ehjci/jeae272, PubMed 39467305
10. Baron SJ, Chou JC, Shah T, Vest AR, Abbott JD, Alasnag M, Aurigemma C, Barbato E, Bellumkonda L, Bortnick AE, Chieffo A, Geuns RV, Grines CL, Halvorsen S, Hassager C, Kapur NK, Naidu SS, Ng VG, Saw J, Lansky AJ (2025)
    SCAI/EAPCI/ACVC Expert Consensus Statement on Cardiogenic Shock in Women: This statement was endorsed by the Heart Failure Society of America (HFSA)
    J Soc Cardiovasc Angiogr Interv, 4 (6), 102150
    DOI 10.1016/j.jscai.2024.102150, PubMed 40630254
11. Baron SJ, Chou JC, Shah T, Vest AR, Abbott JD, Alasnag M, Aurigemma C, Barbato E, Bellumkonda L, Bortnick AE, Chieffo A, van Geuns RJ, Grines CL, Halvorsen S, Hassager C, Kapur NK, Naidu SS, Ng VG, Saw J, Lansky AJ (2025)
    SCAI/EAPCI/ACVC Expert Consensus Statement on Cardiogenic Shock in Women
    EuroIntervention, 21 (16), 894-909
    DOI 10.4244/EIJ-D-24-01126, PubMed 40387531
12. Bondjers K, Hyland P, Atar D, Christensen JO, Nilsen KB, Reitan SK, Rosseland LA, Wentzel-Larsen T, Wøien H, Zwart JA, Dyb G, Stensland S (2025)
    Burnout trajectories among healthcare workers during a pandemic, and predictors of change
    BMC Health Serv Res, 25 (1), 757
    DOI 10.1186/s12913-025-12802-w, PubMed 40426176
13. Bruun LD, Andersen GØ, Kringen MK, Myhre PL, Halvorsen S, Hansen CH, Molden E, Øie E (2025)
    Effect of metoprolol exposure following myocardial infarction on future cardiovascular events: a Mendelian randomization study
    Eur J Clin Pharmacol, 81 (4), 551-560
    DOI 10.1007/s00228-025-03806-w, PubMed 39900827
14. Bønaa KH, Leiren OM, Våga BI, Vangberg G, Govatsmark RES, Kristensen A, Packer EJS, Wiseth R, Aaberge L, Halvorsen S, Mjølstad OC (2025)
    More STEMI patients should receive thrombolytic therapy
    Tidsskr Nor Laegeforen, 145 (8)
    DOI 10.4045/tidsskr.25.0202, PubMed 40575825
15. Chadwick J, Berry C, Carpenter MA, Gulati G, Heck SL, Hinterberg MA, Holman RR, Lee MMY, Omland T, Paterson C, Petrie MC, Sattar N, Shah SH, Shrestha S, Sourij H, Troth EV, Vinje V, Williams SA (2025)
    Utilization of Proteomic Measures for Early Detection of Drug Benefits and Adverse Effects
    J Clin Pharmacol (in press)
    DOI 10.1002/jcph.70077, PubMed 40619592
16. Drexel H, Festa A, Atar D (2025)
    Clinical science at the intersection of cardiovascular, metabolic and renal diseases: new approaches
    Cardiology, 1-5 (in press)
    DOI 10.1159/000547405, PubMed 40790846
17. Engebretsen I, Oteiza F, Birkelund EF, Brandal SM, Bugge C, Halvorsen S (2025)
    Cardiovascular disease in breast cancer patients: a nationwide real-world evidence study 2013-20
    Eur Heart J Open, 5 (3), oeaf043
    DOI 10.1093/ehjopen/oeaf043, PubMed 40313733
18. Engh A, Rueegg CS, Bjerre Trent PK, Opheim LØ, Engeskaug I, Nordskar NJ, Bakken A, Steene-Johannessen J, Eriksson AGZ, Thorsen L (2025)
    Physical activity and lower extremity lymphedema among endometrial cancer survivors: A population-based cross-sectional study
    Gynecol Oncol, 195, 82-88
    DOI 10.1016/j.ygyno.2025.03.009, PubMed 40086214
19. Fyksen TS, Gravning J, Rossebø A, Vanberg P, Grøtta OJ, Atar D, Halvorsen S (2025)
    Cardiac structure and function in anabolic-androgenic steroid users: a 16-year follow-up study
    Open Heart, 12 (2)
    DOI 10.1136/openhrt-2025-003376, PubMed 40759534
20. Gualandro DM, Masip J, Halvorsen S, Price S, Rosselló X, Chioncel O, Peacock WF, Miró Ò, Oliveira Junior MT, Mebazaa A, Platz E, Amir O, Schaubroeck H, Grand J, Sionis A, Tavazzi G, Pöss J, Verbrugge FH, Gambaro A, Tica O, Arrigo M, Mueller C (2025)
    Acute heart failure in non-cardiac surgery
    Eur Heart J (in press)
    DOI 10.1093/eurheartj/ehaf559, PubMed 40838822
21. Haukeland-Parker S, Jervan Ø, Ghanima W, Spruit MA, Holst R, Gleditsch J, Tavoly M, Stavem K, Steine K, Atar D, Dahm AEA, Klok FA, Johannessen HH (2025)
    Exercise capacity, dyspnea, and quality of life 6 months after exercise-based rehabilitation in patients with persistent dyspnea following pulmonary embolism
    Res Pract Thromb Haemost, 9 (2), 102736
    DOI 10.1016/j.rpth.2025.102736, PubMed 40242191
22. Johannessen TR, Melessen IMB, Vallersnes OM, Manten A, Halvorsen S, Atar D, Harskamp RE (2025)
    Adequately identifying low-risk chest pain in emergency primary care: evaluating the performance of preHEAR(T) based on two European cohorts
    Open Heart, 12 (2)
    DOI 10.1136/openhrt-2025-003362, PubMed 40716792
23. Johannessen TR, Ruud SE, Larstorp ACK, Atar D, Halvorsen S, Nilsen B, Vallersnes OM (2025)
    Rapid rule-out of acute myocardial infarction using the 0/1-hour algorithm for cardiac troponins in emergency primary care: the OUT-ACS implementation study
    BMC Prim Care, 26 (1), 34
    DOI 10.1186/s12875-025-02723-2, PubMed 39930354
24. Johannessen TR, Vallersnes OM, Larstorp ACK, Halvorsen S, Atar D (2025)
    One-Hour Troponin Using a High-Sensitivity Point-of-Care Assay in Emergency Primary Care: The OUT-POC Pilot Study
    Cardiology, 1-13 (in press)
    DOI 10.1159/000545127, PubMed 40058362
25. Johannessen TR, Vallersnes OM, Larstorp ACK, Halvorsen S, Atar D (2025)
    Authors' Response Letter - Expanding the Use of Point-of-Care hs-cTnI in Emergency Primary Care: Insights from the OUT-POC Pilot Study
    Cardiology, 1-3 (in press)
    DOI 10.1159/000546344, PubMed 40418919
26. Jortveit J, Myhre PL, Andersen GØ, Halvorsen S (2025)
    Cardiogenic shock as a complication of acute myocardial infarction: a nationwide cohort study
    Eur Heart J Acute Cardiovasc Care (in press)
    DOI 10.1093/ehjacc/zuaf118, PubMed 40973608
27. Jortveit J, Myhre PL, Berge K, Halvorsen S (2025)
    Survival after myocardial infarction according to left ventricular function and heart failure symptoms
    ESC Heart Fail, 12 (4), 2528-2539
    DOI 10.1002/ehf2.15265, PubMed 40101706
28. Jüni P, Antoniou S, Arbelo E, Buccheri S, Cikes M, da Costa BR, Fauchier L, Gale CP, Halvorsen S, James S, Koskinas KC, Kotecha D, Landmesser U, Lewis BS, Løchen ML, Nielsen JC, Rosselló X, Vaartjes I, Prescott EB, Baigent C (2025)
    2024 Revision of the level of evidence grading system for ESC clinical practice guideline recommendations I: therapy and prevention
    Eur Heart J, 46 (20), 1885-1894
    DOI 10.1093/eurheartj/ehaf009, PubMed 40116721
29. Kizilkilic SE, Xu L, Akinci B, Brørs G, Bäck M, Baritello O, Falter M, Halvorsen S, Kaihara T, Kemps H, Mindham R, Mouine N, Ristic J, Salzwedel A, Scherrenberg M, Wilhelm M, Dendale P (2025)
    Educational methods to improve digital health literacy: a systematic review and meta-analysis for the EAPC Opti(MI)se initiative
    Eur J Prev Cardiol (in press)
    DOI 10.1093/eurjpc/zwaf354, PubMed 40659537
30. Kvaran RB, Skagervik A, Pernbro F, Romlin B, Molin M, Wåhlander H, Aass HCD, Vistnes M, Ojala T, Thorlacius EM, Castellheim AG (2025)
    Multivariable Modeling of Postoperative Risk in Infant Cardiac Surgery: Integrating Clinical Variables and 20 Inflammatory Biomarkers
    Acta Anaesthesiol Scand, 69 (6), e70073
    DOI 10.1111/aas.70073, PubMed 40492379
31. Lamy A, Sandhu RK, Tong W, McIntyre WF, Lopes RD, Granger CB, Wright DJ, Nielsen JC, Kutyifa V, Erath JW, Alings M, Birnie DH, Atar D, Hohnloser SH, Linde C, Kautzner J, Benezet-Mazuecos J, Camm AJ, Sticherling C, Gold MR, Larroudé CE, Healey JS (2025)
    Cost-effectiveness of apixaban vs. aspirin for the reduction of thrombo-embolism in high-risk patients with device-detected atrial fibrillation: insights from the ARTESiA trial
    Europace, 27 (9)
    DOI 10.1093/europace/euaf195, PubMed 40886070
32. Munkhaugen J, Kristensen AMD, Halvorsen S, Holmager T, Olsen MH, Bakken A, Sehested TSG, Ruddox V, Mæng M, Vikenes K, Jensen SE, Steigen T, Lambrechtsen J, Jortveit J, Bovin A, Schirmer H, Christiansen MK, Wiseth R, Mikkelsen D, Larsen AI, Kjærgaard CL, Andresen K, Gustafsson I, Tuseth V, Larsen ML et al. (2025)
    Beta-Blockers after Myocardial Infarction in Patients without Heart Failure
    N Engl J Med (in press)
    DOI 10.1056/NEJMoa2505985, PubMed 40888716
33. Ni W, Stafoggia M, Zhang S, Ljungman P, Breitner S, de Bont J, Jernberg T, Atar D, Schneider A, Agewall S (2025)
    Short-term exposure to ambient temperature variability and myocardial infarction hospital admissions: A nationwide case-crossover study in Sweden
    PLoS Med, 22 (5), e1004607
    DOI 10.1371/journal.pmed.1004607, PubMed 40392899
34. Omland T, Heck SL, Holte E, Mecinaj Lilleaasen A, Gynnild MN, Fagerland MW, Vinje-Jakobsen V, Næs AL, Blix ES, Larsen AI, Geisler J, Gulati G, Wethal T (2025)
    Sacubitril-Valsartan and Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy: The PRADA II Randomized Clinical Trial
    Circulation (in press)
    DOI 10.1161/CIRCULATIONAHA.125.076616, PubMed 40884047
35. Pope MK, Chugh H, Sargsyan A, Uy-Evanado A, Salvucci A, Jui J, Reinier K, Chugh SS (2025)
    Temporal trends in left ventricular ejection fraction before sudden death in patients with heart failure
    Heart Rhythm, 22 (8), 1984-1993
    DOI 10.1016/j.hrthm.2025.05.013, PubMed 40368293
36. Pope MK, Chugh SS (2025)
    Static Versus Dynamic Risk of Sudden Cardiac Death: Implications for Improvement of Prediction and Prevention
    J Cardiovasc Electrophysiol (in press)
    DOI 10.1111/jce.16654, PubMed 40129232
37. Rakisheva A, Farmakis D, Attanasio A, Genis AB, Cohen-Solal A, Gulati G, Halle M, Hill L, Fernandez TL, Lyon AR, Moura B, Santoro C, Tocchetti CG, van Linthout S, Vassiliou V, Sener YZ, Bekbosynova M, Metra M, Rosano G, Piepoli M (2025)
    Prevention of cancer therapy-related cardiac dysfunction and heart failure in cancer patients and survivors. A Clinical Consensus Statement of the Heart Failure Association, the European Association of Preventive Cardiology of the ESC, and the ESC Council of Cardio-Oncology
    Eur J Heart Fail (in press)
    DOI 10.1002/ejhf.3753, PubMed 40679941
38. Rossello X, Prescott EIB, Kristensen AMD, Latini R, Fuster V, Fagerland MW, Pocock SJ, Halvorsen S, Dominguez-Rodriguez A, Holmager TLF, Sanchez PL, Bakken A, Raposeiras-Roubin S, Jensen SE, Kimura T, Ottani F, Lambrechtsen J, Anguita M, Ozasa N, Atar D, Ibanez B, Munkhaugen J (2025)
    β blockers after myocardial infarction with mildly reduced ejection fraction: an individual patient data meta-analysis of randomised controlled trials
    Lancet, 406 (10508), 1128-1137
    DOI 10.1016/S0140-6736(25)01592-2, PubMed 40897190
39. Stensland SØ, Bondjers K, Zwart JA, Rosseland LA, Atar D, Christensen JO, Matre D, Glad KA, Wentzel-Larsen T, Wøien H, Dyb G (2025)
    Development and psychometric validation of the frontline health workers' occupational risk and characteristics in emergencies index (FORCE-index) - The covid Hospital cohort study
    Public Health Pract (Oxf), 9, 100582
    DOI 10.1016/j.puhip.2025.100582, PubMed 39896339
40. Vranckx P, Halvorsen S (2025)
    Cracking the clot: the RIVAWAR trial challenges warfarin's reign in left ventricular thrombus post-acute coronary syndrome
    Eur Heart J Acute Cardiovasc Care, 14 (4), 243-244
    DOI 10.1093/ehjacc/zuaf052, PubMed 40171935
41. Vranckx P, Pavlov M, Halvorsen S (2025)
    The NEO-MINDSET trial: immediate aspirin withdrawal after percutaneous coronary intervention for acute coronary syndrome-remains a therapeutic no-man's land
    Eur Heart J Acute Cardiovasc Care (in press)
    DOI 10.1093/ehjacc/zuaf116, PubMed 40973200
42. Aaseth E, Halvorsen S, Helseth R, Gravning JA (2025)
    Remnant cholesterol, plasma triglycerides and risk of cardiovascular disease events in young adults: a prospective cohort study
    Eur J Prev Cardiol (in press)
    DOI 10.1093/eurjpc/zwaf104, PubMed 40007056

Publications 2024

1. Alrahimi J, Ahmed FA, Atar D (2024)
   The Interplay of Atherothrombotic Factors and the Evolving Landscape of Atherosclerotic Cardiovascular Disease: Comprehensive Insights from Recent Studies
   Anatol J Cardiol, 28 (8), 375-80 (in press)
   DOI 10.14744/AnatolJCardiol.2024.4632, PubMed 39011832
2. Andel PM, Aamodt AH, Gleditsch J, Melin E, Rootwelt-Revheim ME, Steine K, Atar D (2024)
   Elective Direct Current Cardioversion of Atrial Fibrillation: Silent Brain Infarction and Health-Related Quality of Life
   Cardiology, 149 (6), 571-579
   DOI 10.1159/000540007, PubMed 39025051
3. Andrup S, Andersen GØ, Hoffmann P, Eritsland J, Seljeflot I, Halvorsen S, Vistnes M (2024)
   Novel cardiac extracellular matrix biomarkers in STEMI: Associations with ischemic injury and long-term mortality
   PLoS One, 19 (5), e0302732
   DOI 10.1371/journal.pone.0302732, PubMed 38739599
4. Atar D, Munkhaugen J, Sverre E (2024)
   Statin discontinuation: How can we improve on the multiple pathways that contribute to suboptimal statin adherence?
   Kardiol Pol, 82 (9), 828-830
   DOI 10.33963/v.phj.102335, PubMed 39240921
5. Aune A, Ohldieck A, Halvorsen LV, Brobak KM, Olsen E, Rognstad S, Larstorp ACK, Søraas CL, Rossebø AB, Rösner A, Grytaas MA, Gerdts E (2024)
   Gender Differences in Cardiac Organ Damage in Arterial Hypertension: Assessing the Role of Drug Nonadherence
   High Blood Press Cardiovasc Prev, 31 (2), 157-166
   DOI 10.1007/s40292-024-00632-6, PubMed 38530572
6. Bondjers K, Glad AK, Wøien H, Wentzel-Larsen T, Atar D, Reitan SK, Rosseland LA, Zwart JA, Dyb G, Stensland SØ (2024)
   Moral distress and protective work environment for healthcare workers during public health emergencies
   BMC Med Ethics, 25 (1), 103
   DOI 10.1186/s12910-024-01098-w, PubMed 39354454
7. Boskovic M, Jortveit J, Haraldsen MB, Berge T, Engdahl J, Løchen ML, Schuster P, Sandberg EL, Grimsmo J, Atar D, Anfinsen OG, Pripp AH, Grenne BL, Halvorsen S (2024)
   The NORwegian atrial fibrillation self-SCREENing (NORSCREEN) trial: rationale and design of a randomized controlled trial
   Europace, 26 (10)
   DOI 10.1093/europace/euae228, PubMed 39248170
8. Engebretsen I, Bugge C, Støvring H, Husebye E, Sverre E, Dammen T, Halvorsen S, Munkhaugen J (2024)
   Treatment patterns and adherence to lipid-lowering drugs during eight-year follow-up after a coronary heart disease event
   Atherosclerosis, 393, 117550
   DOI 10.1016/j.atherosclerosis.2024.117550, PubMed 38657552
9. Engebretsen I, Malene Ødegaard K, Halvorsen S, Bugge C, Kristiansen IS, Støvring H, Munkhaugen J (2024)
   Treatment with PCSK9 monoclonal antibodies is associated with discontinuation of oral lipid lowering therapy
   Eur Heart J Qual Care Clin Outcomes (in press)
   DOI 10.1093/ehjqcco/qcae099, PubMed 39562279
10. Fyksen TS, Seljeflot I, Vanberg P, Atar D, Halvorsen S (2024)
    Platelet activity, coagulation, and fibrinolysis in long-term users of anabolic-androgenic steroids compared to strength-trained athletes
    Thromb Res, 238, 60-66
    DOI 10.1016/j.thromres.2024.04.027, PubMed 38676967
11. Gigante B, Tamargo J, Agewall S, Atar D, Ten Berg J, Campo G, Cerbai E, Christersson C, Dobrev D, Ferdinandy P, Geisler T, Gorog DA, Grove EL, Kaski JC, Rubboli A, Wassmann S, Wallen H, Rocca B (2024)
    Update on antithrombotic therapy and body mass: a clinical consensus statement of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and the European Society of Cardiology Working Group on Thrombosis
    Eur Heart J Cardiovasc Pharmacother, 10 (7), 614-645
    DOI 10.1093/ehjcvp/pvae064, PubMed 39237457
12. Gulati G, Broberg AM, Offersen BV (2024)
    The Nordic Cardio-Oncology Society: mission and future goals
    Eur Heart J, 45 (21), 1869-1871
    DOI 10.1093/eurheartj/ehae014, PubMed 38607440
13. Gurholt TP, Elvsåshagen T, Bahrami S, Rahman Z, Shadrin A, Askeland-Gjerde DE, van der Meer D, Frei O, Kaufmann T, Sønderby IE, Halvorsen S, Westlye LT, Andreassen OA (2024)
    Large-scale brainstem neuroimaging and genetic analyses provide new insights into the neuronal mechanisms of hypertension
    HGG Adv, 6 (1), 100392
    DOI 10.1016/j.xhgg.2024.100392, PubMed 39663699
14. Hadziselimovic E, Greve AM, Sajadieh A, Olsen MH, Nienaber CA, Ray SG, Rossebø AB, Wachtell K, Dominguez H, Valeur N, Carstensen HG, Nielsen OW (2024)
    Development and validation of the ASGARD risk score for safe monitoring in asymptomatic nonsevere aortic stenosis
    Eur J Prev Cardiol (in press)
    DOI 10.1093/eurjpc/zwae086, PubMed 38416125
15. Halvorsen S, Hassager C (2024)
    Cardiogenic shock in women: From risk factors to therapy
    Kardiol Pol, 82 (11), 1071-1075
    DOI 10.33963/v.phj.103739, PubMed 39737611
16. Halvorsen S, Vranckx P, van Diepen S (2024)
    Should renin-angiotensin system inhibitors be stopped or not before non-cardiac surgery?
    Eur Heart J Acute Cardiovasc Care, 13 (9), 670-671
    DOI 10.1093/ehjacc/zuae101, PubMed 39257308
17. Jortveit J, Andersen GØ, Halvorsen S (2024)
    Short- and long-term outcomes of patients with acute myocardial infarction complicated by cardiac arrest: a nationwide cohort study 2013-22
    Eur Heart J Acute Cardiovasc Care, 13 (12), 828-837
    DOI 10.1093/ehjacc/zuae121, PubMed 39441985
18. Jortveit J, Boskovic M, Sandberg EL, Vegsundvåg J, Halvorsen S (2024)
    High Diagnostic Accuracy of Long-Term Electrocardiogram Interpretation by General Practitioners
    Int J Telemed Appl, 2024, 6624344
    DOI 10.1155/2024/6624344, PubMed 38425473
19. Kristensen AMD, Munkhaugen J, Halvorsen S, Olsen MH, Bakken A, Sehested TSG, Ruddox V, Lange T, Fagerland MW, Torp-Pedersen C, Prescott E, Atar D (2024)
    The Danish-Norwegian randomized trial on beta-blocker therapy after myocardial infarction: Design, rationale, and baseline characteristics
    Eur Heart J Cardiovasc Pharmacother, 10 (3), 175-183
    DOI 10.1093/ehjcvp/pvad093, PubMed 38017624
20. Lambert AT, Sætre DO, Ratajczak-Tretel B, Gleditsch J, Høie G, Al-Ani R, Pesonen M, Atar D, Aamodt AH (2024)
    Imaging features for the identification of atrial fibrillation in cryptogenic stroke patients
    J Neurol, 271 (8), 5343-5356
    DOI 10.1007/s00415-024-12397-y, PubMed 38904781
21. Landi A, Aboyans V, Angiolillo DJ, Atar D, Capodanno D, Fox KAA, Halvorsen S, James S, Jüni P, Leonardi S, Mehran R, Montalescot G, Navarese EP, Niebauer J, Oliva A, Piccolo R, Price S, Storey RF, Völler H, Vranckx P, Windecker S, Valgimigli M (2024)
    Antithrombotic therapy in patients with acute coronary syndrome: similarities and differences between a European expert consensus document and the 2023 European Society of Cardiology guidelines
    Eur Heart J Acute Cardiovasc Care, 13 (1), 173-180
    DOI 10.1093/ehjacc/zuad158, PubMed 38170562
22. Langslet G, Nyström T, Vistisen D, Carstensen B, Grip ET, Casajust P, Tskhvarashvili G, Hoti F, Klement R, Karlsdotter K, Tuovinen M, Ofstad AP, Lajer M, Shay C, Koeneman L, Farsani SF, Niskanen L, Halvorsen S (2024)
    Empagliflozin Use Is Associated With Lower Risk of All-Cause Mortality, Hospitalization for Heart Failure, and End-Stage Renal Disease Compared to DPP-4i in Nordic Type 2 Diabetes Patients: Results From the EMPRISE (Empagliflozin Comparative Effectiveness and Safety) Study
    J Diabetes Res, 2024, 6142211
    DOI 10.1155/2024/6142211, PubMed 39430801
23. Lopes RD, Granger CB, Wojdyla DM, McIntyre WF, Alings M, Mani T, Ramasundarahettige C, Rivard L, Atar D, Birnie DH, Boriani G, Amit G, Leong-Sit P, Rinne C, Duray GZ, Gold MR, Hohnloser SH, Kutyifa V, Benezet-Mazuecos J, Cosedis Nielsen J, Sticherling C, Benz AP, Linde C, Kautzner J, Mabo P et al. (2024)
    Apixaban vs Aspirin According to CHA₂DS₂-VASc Score in Subclinical Atrial Fibrillation: Insights From ARTESiA
    J Am Coll Cardiol, 84 (4), 354-364
    DOI 10.1016/j.jacc.2024.05.002, PubMed 39019530
24. McClintick DJ, O'Donoghue ML, De Ferrari GM, Ferreira J, Ran X, Im K, López JAG, Elliott-Davey M, Wang B, Monsalvo ML, Atar D, Keech A, Giugliano RP, Sabatine MS (2024)
    Long-Term Efficacy of Evolocumab in Patients With or Without Multivessel Coronary Disease
    J Am Coll Cardiol, 83 (6), 652-664
    DOI 10.1016/j.jacc.2023.11.029, PubMed 38325990
25. Mecinaj A, Gulati G, Omland T, Heck SL (2024)
    Reply: Probing the Anthracycline-Induced Myocardial Injury: A Glimpse Through the Lens of the PRADA Trial
    JACC CardioOncol, 6 (4), 630
    DOI 10.1016/j.jaccao.2024.05.010, PubMed 39239351
26. Mecinaj A, Gulati G, Ree AH, Gravdehaug B, Røsjø H, Steine K, Wisløff T, Geisler J, Omland T, Heck SL (2024)
    Impact of the ESC Cardio-Oncology Guidelines Biomarker Criteria on Incidence of Cancer Therapy-Related Cardiac Dysfunction
    JACC CardioOncol, 6 (1), 83-95
    DOI 10.1016/j.jaccao.2023.10.008, PubMed 38510299
27. Ni W, Stafoggia M, Zhang S, Ljungman P, Breitner S, Bont J, Jernberg T, Atar D, Agewall S, Schneider A (2024)
    Short-Term Effects of Lower Air Temperature and Cold Spells on Myocardial Infarction Hospitalizations in Sweden
    J Am Coll Cardiol, 84 (13), 1149-1159
    DOI 10.1016/j.jacc.2024.07.006, PubMed 39230547
28. Nordlund D, Lav T, Jablonowski R, Khoshnood A, Ekelund U, Atar D, Erlinge D, Engblom H, Arheden H (2024)
    Contractility, ventriculoarterial coupling, and stroke work after acute myocardial infarction using CMR-derived pressure-volume loop data
    Clin Cardiol, 47 (1), e24216
    DOI 10.1002/clc.24216, PubMed 38269628
29. Rubboli A, Atar D, Sibbing D (2024)
    De-escalation of antithrombotic treatment after acute coronary syndrome, a new paradigm
    Intern Emerg Med, 19 (6), 1537-1548
    DOI 10.1007/s11739-024-03590-y, PubMed 38594458
30. Sambola A, Halvorsen S, Adlam D, Hassager C, Price S, Rosano G, Schiele F, Holmvang L, de Riva M, Rakisheva A, Sulzgruber P, Swahn E (2024)
    Management of cardiac emergencies in women: a clinical consensus statement of the Association for Acute CardioVascular Care (ACVC), the European Association of Percutaneous Cardiovascular Interventions (EAPCI), the Heart Failure Association (HFA), and the European Heart Rhythm Association (EHRA) of the ESC, and the ESC Working Group on Cardiovascular Pharmacotherapy
    Eur Heart J Open, 4 (2), oeae011
    DOI 10.1093/ehjopen/oeae011, PubMed 38628674
31. Sandberg EL, Halvorsen S, Berge T, Grimsmo J, Atar D, Grenne BL, Jortveit J (2024)
    Screening for Atrial Fibrillation by Digital Health Technology in Older People in Homecare Settings: A Feasibility Trial
    Int J Telemed Appl, 2024, 4080415
    DOI 10.1155/2024/4080415, PubMed 38567031
32. Sandberg EL, Halvorsen S, Berge T, Grimsmo J, Atar D, Leangen Grenne B, Jortveit J (2024)
    Digital recruitment and compliance to treatment recommendations in the Norwegian Atrial Fibrillation self-screening pilot study
    Eur Heart J Digit Health, 5 (3), 371-378
    DOI 10.1093/ehjdh/ztae026, PubMed 38774377
33. Schlotter F, Huber K, Hassager C, Halvorsen S, Vranckx P, Pöss J, Krychtiuk K, Lorusso R, Bonaros N, Calvert PA, Montorfano M, Thiele H (2024)
    Ventricular septal defect complicating acute myocardial infarction: diagnosis and management. A Clinical Consensus Statement of the Association for Acute CardioVascular Care (ACVC) of the ESC, the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC and the ESC Working Group on Cardiovascular Surgery
    Eur Heart J, 45 (28), 2478-2492
    DOI 10.1093/eurheartj/ehae363, PubMed 38888906
34. Schnabel RB, Benezet-Mazuecos J, Becher N, McIntyre WF, Fierenz A, Lee SF, Goette A, Atar D, Bertaglia E, Benz AP, Chlouverakis G, Birnie DH, Dichtl W, Blomstrom-Lundqvist C, Camm AJ, Erath JW, Simantirakis E, Kutyifa V, Lip GYH, Mabo P, Marijon E, Rivard L, Schotten U, Alings M, Sehner S et al. (2024)
    Anticoagulation in device-detected atrial fibrillation with or without vascular disease: a combined analysis of the NOAH-AFNET 6 and ARTESiA trials
    Eur Heart J, 45 (46), 4902-4916
    DOI 10.1093/eurheartj/ehae596, PubMed 39222018
35. Skjøth F, Larsen TB, Dun AR, Lilja M, Rahman I, Abdelgawwad K, Halvorsen S, Coleman C, Rivera M (2024)
    Comparative Safety and Effectiveness of Reduced Doses of Direct Acting Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation
    Am J Med, 137 (6), 520-528.e13
    DOI 10.1016/j.amjmed.2024.02.005, PubMed 38387539
36. Sternberg Z, Podolsky R, Yu J, Hua S, Halvorsen S, Hojnacki D, Schaller BJ (2024)
    Anti-Hypertensives Reduce the Rate of Alzheimer's Disease Progression: A Cohort Study Linked with Genetic and Neuropathological Analyses
    J Prev Alzheimers Dis, 11 (6), 1634-1646
    DOI 10.14283/jpad.2024.156, PubMed 39559876
37. Tocchetti CG, Farmakis D, Koop Y, Andres MS, Couch LS, Formisano L, Ciardiello F, Pane F, Au L, Emmerich M, Plummer C, Gulati G, Ramalingam S, Cardinale D, Brezden-Masley C, Iakobishvili Z, Thavendiranathan P, Santoro C, Bergler-Klein J, Keramida K, de Boer RA, Maack C, Lutgens E, Rassaf T, Fradley MG et al. (2024)
    Cardiovascular toxicities of immune therapies for cancer - a scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-Oncology
    Eur J Heart Fail, 26 (10), 2055-2076
    DOI 10.1002/ejhf.3340, PubMed 39087551
38. Tsaban G, Perez RV, Krychtiuk KA, Ahrens I, Halvorsen S, Hassager C, Huber K, Schiele F, Sionis A, Claeys MJ (2024)
    Lipid-lowering therapy after acute coronary syndromes: a multinational European survey
    Coron Artery Dis, 36 (1), 51-58
    DOI 10.1097/MCA.0000000000001420, PubMed 39263716
39. van Diepen S, Halvorsen S, Menon V (2024)
    The REDUCE-AMI trial: an important step in cardiovascular drug de-prescription
    Eur Heart J Acute Cardiovasc Care, 13 (4), 370-372
    DOI 10.1093/ehjacc/zuae049, PubMed 38608152
40. Vistnes M (2024)
    Survival of the strongest: can muscular strength measurements be used in prevention of heart failure in patients with acute coronary syndromes?
    Eur J Prev Cardiol, 31 (7), 832-833
    DOI 10.1093/eurjpc/zwae047, PubMed 38381591
41. Vistnes M (2024)
    Hitting the Target! Challenges and Opportunities for TGF-β Inhibition for the Treatment of Cardiac fibrosis
    Pharmaceuticals (Basel), 17 (3)
    DOI 10.3390/ph17030267, PubMed 38543053
42. Xiong W, Agewall S, Yamashita Y (2024)
    Anticoagulation in cancer-associated thrombosis: how long should the therapy be?
    Eur Heart J Cardiovasc Pharmacother, 10 (1), 3-4
    DOI 10.1093/ehjcvp/pvad075, PubMed 37827545
43. Zimerman A, O'Donoghue ML, Ran X, Im K, Ott BR, Mach F, Zavitz K, Kurtz CE, Monsalvo ML, Wang B, Atar D, Keech A, Sabatine MS, Giugliano RP (2024)
    Long-Term Cognitive Safety of Achieving Very Low LDL Cholesterol with Evolocumab
    NEJM Evid, 4 (1), EVIDoa2400112
    DOI 10.1056/EVIDoa2400112, PubMed 39718423
44. Aaseth E, Christiansen JR (2024)
    Prevalence of transthyretin amyloid cardiomyopathy in pacemaker patients
    ESC Heart Fail, 11 (2), 871-876
    DOI 10.1002/ehf2.14645, PubMed 38204282

Publications 2023

1. Agewall S (2023)
   Atrial fibrillation has gone from a boring disease to a very hot condition. Why is that?
   Eur Heart J Cardiovasc Pharmacother, 9 (5), 401-402
   DOI 10.1093/ehjcvp/pvad049, PubMed 37486237
2. Andel PM, Aukrust P, Gleditsch J, Gude E, Haugeberg G, Høie S, Salte T, Steine K, Atar D (2023)
   Recurrent pericarditis
   Tidsskr Nor Laegeforen, 143 (8)
   DOI 10.4045/tidsskr.22.0580, PubMed 37254974
3. Andreotti F, Geisler T, Collet JP, Gigante B, Gorog DA, Halvorsen S, Lip GYH, Morais J, Navarese EP, Patrono C, Rocca B, Rubboli A, Sibbing D, Storey RF, Verheugt FWA, Vilahur G (2023)
   Acute, periprocedural and longterm antithrombotic therapy in older adults: 2022 Update by the ESC Working Group on Thrombosis
   Eur Heart J, 44 (4), 262-279
   DOI 10.1093/eurheartj/ehac515, PubMed 36477865
4. Atar D, Auricchio A, Blomström-Lundqvist C (2023)
   Cardiac device infection: removing barriers to timely and adequate treatment
   Eur Heart J, 44 (35), 3323-3326
   DOI 10.1093/eurheartj/ehad490, PubMed 37529893
5. Atar D, Bakken A, Munkhaugen J (2023)
   Achieving the unachievable: How to optimize lipid-lowering therapy in survivors of acute myocardial infarction
   Kardiol Pol, 81 (4), 327-329
   DOI 10.33963/KP.a2023.0087, PubMed 37144720
6. Atar D, Rosseland LA, Jammer I, Aakre KM, Wiseth R, Molund M, Gualandro DM, Omland T (2023)
   Implementing screening for myocardial injury in non-cardiac surgery: perspectives of an ad-hoc interdisciplinary expert group
   Scand Cardiovasc J, 57 (1), 31-39
   DOI 10.1080/14017431.2022.2112071, PubMed 37141087
7. Bondjers K, Lingaas I, Stensland S, Atar D, Zwart JA, Wøien H, Dyb G (2023)
   "I've kept going" - a multisite repeated cross-sectional study of healthcare workers' pride in personal performance during the COVID-19 pandemic
   BMC Health Serv Res, 23 (1), 322
   DOI 10.1186/s12913-023-09246-5, PubMed 37004056
8. Drexel H, Saely CH, Agewall S (2023)
   Fibrates: one more lost paradise in lipid treatment
   Eur Heart J Cardiovasc Pharmacother, 9 (2), 121
   DOI 10.1093/ehjcvp/pvac072, PubMed 36610735
9. Fröhlich H, Bossmeyer A, Kazmi S, Goode KM, Agewall S, Atar D, Grundtvig M, Frey N, Cleland JGF, Frankenstein L, Clark AL, Täger T (2023)
   Glycaemic control and insulin therapy are significant confounders of the obesity paradox in patients with heart failure and diabetes mellitus
   Clin Res Cardiol, 113 (6), 822-830
   DOI 10.1007/s00392-023-02268-3, PubMed 37608126
10. Gencer B, Gale CP, Aktaa S, Halvorsen S, Beska B, Abdelhamid M, Mueller C, Tutarel O, McGreavy P, Schirmer H, Geissler T, Sillesen H, Niessner A, Zacharowski K, Mehilli J, Potpara T (2023)
    European Society of Cardiology quality indicators for the cardiovascular pre-operative assessment and management of patients considered for non-cardiac surgery. Developed in collaboration with the European Society of Anaesthesiology and Intensive Care
    Eur Heart J Qual Care Clin Outcomes, 9 (4), 331-341
    DOI 10.1093/ehjqcco/qcac057, PubMed 36069905
11. Gorog DA, Ferreiro JL, Ahrens I, Ako J, Geisler T, Halvorsen S, Huber K, Jeong YH, Navarese EP, Rubboli A, Sibbing D, Siller-Matula JM, Storey RF, Tan JWC, Ten Berg JM, Valgimigli M, Vandenbriele C, Lip GYH (2023)
    De-escalation or abbreviation of dual antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention: a Consensus Statement from an international expert panel on coronary thrombosis
    Nat Rev Cardiol, 20 (12), 830-844
    DOI 10.1038/s41569-023-00901-2, PubMed 37474795
12. Hadziselimovic E, Greve AM, Sajadieh A, Olsen MH, Kesäniemi YA, Nienaber CA, Ray SG, Rossebø AB, Wachtell K, Nielsen OW (2023)
    Association of high-sensitivity troponin T with outcomes in asymptomatic non-severe aortic stenosis: a post-hoc substudy of the SEAS trial
    EClinicalMedicine, 58, 101875
    DOI 10.1016/j.eclinm.2023.101875, PubMed 36915288
13. Halvorsen S, Mehilli J, Cassese S, Hall TS, Abdelhamid M, Barbato E, De Hert S, de Laval I, Geisler T, Hinterbuchner L, Ibanez B, Lenarczyk R, Mansmann UR, McGreavy P, Mueller C, Muneretto C, Niessner A, Potpara TS, Ristić A, Sade LE, Schirmer H, Schüpke S, Sillesen H, Skulstad H, Torracca L et al. (2023)
    [2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery Developed by the task force for cardiovascular assessment and management of patients undergoing non-cardiac surgery of the European Society of Cardiology (ESC) Endorsed by the European Society of Anaesthesiology and Intensive Care (ESAIC)]
    G Ital Cardiol (Rome), 24 (1 Suppl 1), e1-e102
    DOI 10.1714/3956.39326, PubMed 36645369
14. Halvorsen S, Mehilli J, Choorapoikayil S, Zacharowski K (2023)
    Extract from the 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery - Patient Blood Management
    Blood Transfus, 22 (2), 122-129
    DOI 10.2450/BloodTransfus.708, PubMed 38063786
15. Halvorsen S, Mehilli J, Geisler T (2023)
    Continue or discontinue aspirin before non-cardiac surgery?
    Eur Heart J, 44 (26), 2410
    DOI 10.1093/eurheartj/ehad246, PubMed 37155334
16. Halvorsen S, Mehilli J, Mueller C (2023)
    The roles of cardiac troponins before non-cardiac surgery
    Eur Heart J, 44 (23), 2130-2131
    DOI 10.1093/eurheartj/ehad226, PubMed 37098747
17. Healey JS, Lopes RD, Granger CB, Alings M, Rivard L, McIntyre WF, Atar D, Birnie DH, Boriani G, Camm AJ, Conen D, Erath JW, Gold MR, Hohnloser SH, Ip J, Kautzner J, Kutyifa V, Linde C, Mabo P, Mairesse G, Benezet Mazuecos J, Cosedis Nielsen J, Philippon F, Proietti M, Sticherling C et al. (2023)
    Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation
    N Engl J Med, 390 (2), 107-117
    DOI 10.1056/NEJMoa2310234, PubMed 37952132
18. Holm NR, Andreasen LN, Neghabat O, Laanmets P, Kumsars I, Bennett J, Olsen NT, Odenstedt J, Hoffmann P, Dens J, Chowdhary S, O'Kane P, Bülow Rasmussen SH, Heigert M, Havndrup O, Van Kuijk JP, Biscaglia S, Mogensen LJH, Henareh L, Burzotta F, H Eek C, Mylotte D, Llinas MS, Koltowski L, Knaapen P et al. (2023)
    OCT or Angiography Guidance for PCI in Complex Bifurcation Lesions
    N Engl J Med, 389 (16), 1477-1487
    DOI 10.1056/NEJMoa2307770, PubMed 37634149
19. Jervan Ø, Haukeland-Parker S, Gleditsch J, Tavoly M, Klok FA, Steine K, Johannessen HH, Spruit MA, Atar D, Holst R, Astrup Dahm AE, Sirnes PA, Stavem K, Ghanima W (2023)
    The Effects of Exercise Training in Patients With Persistent Dyspnea Following Pulmonary Embolism: A Randomized Controlled Trial
    Chest, 164 (4), 981-991
    DOI 10.1016/j.chest.2023.04.042, PubMed 37149257
20. Karasik A, Lanzinger S, Chia-Hui Tan E, Yabe D, Kim DJ, Sheu WH, Melzer-Cohen C, Holl RW, Ha KH, Khunti K, Zaccardi F, Subramanian A, Nirantharakumar K, Nyström T, Niskanen L, Linnemann Jensen M, Hoti F, Klement R, Déruaz-Luyet A, Kyaw MH, Koeneman L, Vistisen D, Carstensen B, Halvorsen S, Langslet G et al. (2023)
    Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study
    Diabetes Metab, 49 (2), 101418
    DOI 10.1016/j.diabet.2022.101418, PubMed 36608816
21. Knutsen TM, Skretteberg PT, Vanberg P, Kamal Z, Halvorsen S, Liestøl K, Steen T, Platou E (2023)
    Transvenous lead extractions in a single high-volume center over a 24-year period: High success rate and low complication rate
    Heart Rhythm O2, 4 (4), 232-240
    DOI 10.1016/j.hroo.2023.01.003, PubMed 37124554
22. López-Fernández T, Farmakis D, Ameri P, Asteggiano R, de Azambuja E, Aznar M, Barac A, Bayes-Genis A, Bax JJ, Bergler-Klein J, Boriani G, Celutkiene J, Coats A, Cohen-Solal A, Córdoba R, Cosyns B, Filippatos G, Fox K, Gulati G, Inciardi RM, Lee G, Mamas MA, Novo G, Plummer C, Psyrri A et al. (2023)
    European Society of Cardiology Core Curriculum for cardio-oncology
    Eur J Heart Fail, 26 (4), 754-771
    DOI 10.1002/ejhf.3102, PubMed 38059343
23. Lundin M, Heiberg E, Nordlund D, Gyllenhammar T, Steding-Ehrenborg K, Engblom H, Carlsson M, Atar D, van der Pals J, Erlinge D, Borgquist R, Khoshnood A, Ekelund U, Nickander J, Themudo R, Nordin S, Kozor R, Bhuva AN, Moon JC, Maret E, Caidahl K, Sigfridsson A, Sörensson P, Schelbert EB, Arheden H et al. (2023)
    Prognostic utility and characterization of left ventricular hypertrophy using global thickness
    Sci Rep, 13 (1), 22806
    DOI 10.1038/s41598-023-48173-7, PubMed 38129418
24. Mehilli J, Halvorsen S (2023)
    The '10 commandments' for the 2022 European Society of Cardiology guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
    Eur Heart J, 44 (5), 336-337
    DOI 10.1093/eurheartj/ehac703, PubMed 36527277
25. Menon V, Halvorsen S (2023)
    The second strategic reperfusion early after myocardial infarction (STREAM-2) study
    Eur Heart J Acute Cardiovasc Care, 12 (4), 219-221
    DOI 10.1093/ehjacc/zuad024, PubMed 36895183
26. Navarese EP, Landi A, Oliva A, Piccolo R, Aboyans V, Angiolillo D, Atar D, Capodanno D, Fox KAA, Halvorsen S, James S, Jüni P, Kunadian V, Leonardi S, Mehran R, Montalescot G, Niebauer J, Price S, Storey RF, Völler H, Vranckx P, Windecker S, Valgimigli M (2023)
    Within and beyond 12-month efficacy and safety of antithrombotic strategies in patients with established coronary artery disease: two companion network meta-analyses of the 2022 joint clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Association for Acute CardioVascular Care (ACVC), and European Association of Preventive Cardiology (EAPC)
    Eur Heart J Cardiovasc Pharmacother, 9 (3), 271-290
    DOI 10.1093/ehjcvp/pvad016, PubMed 36869784
27. Nguyen THP, Fagerland MW, Hollan I, Whist JE, Feinberg MW, Agewall S (2023)
    High-sensitivity cardiac troponin T is associated with disease activity in patients with inflammatory arthritis
    PLoS One, 18 (2), e0281155
    DOI 10.1371/journal.pone.0281155, PubMed 36763689
28. Pope MK, Hall TS, Virdone S, Atar D, John Camm A, Pieper KS, Jansky P, Haas S, Goto S, Panchenko E, Baron-Esquivias G, Angchaisuksiri P, Kakkar AK, GARFIELD-AF Investigators (2023)
    Rhythm versus rate control in patients with newly diagnosed atrial fibrillation - Observations from the GARFIELD-AF registry
    Int J Cardiol Heart Vasc, 49, 101302
    DOI 10.1016/j.ijcha.2023.101302, PubMed 38020059
29. Ratajczak-Tretel B, Lambert AT, Al-Ani R, Arntzen K, Bakkejord GK, Bekkeseth HMO, Bjerkeli V, Eldøen G, Gulsvik AK, Halvorsen B, Høie GA, Ihle-Hansen H, Ihle-Hansen H, Ingebrigtsen S, Kremer C, Krogseth SB, Kruuse C, Kurz M, Nakstad I, Novotny V, Næss H, Qazi R, Rezaj MK, Rørholt DM, Steffensen LH et al. (2023)
    Prediction of underlying atrial fibrillation in patients with a cryptogenic stroke: results from the NOR-FIB Study
    J Neurol, 270 (8), 4049-4059
    DOI 10.1007/s00415-023-11680-8, PubMed 37162578
30. Ratajczak-Tretel B, Lambert AT, Al-Ani R, Arntzen K, Bakkejord GK, Bekkeseth HMO, Bjerkeli V, Eldøen G, Gulsvik AK, Halvorsen B, Høie GA, Ihle-Hansen H, Ingebrigtsen S, Kremer C, Krogseth SB, Kruuse C, Kurz M, Nakstad I, Novotny V, Naess H, Qazi R, Rezaj MK, Rørholt DM, Steffensen LH, Sømark J et al. (2023)
    Underlying causes of cryptogenic stroke and TIA in the nordic atrial fibrillation and stroke (NOR-FIB) study - the importance of comprehensive clinical evaluation
    BMC Neurol, 23 (1), 115
    DOI 10.1186/s12883-023-03155-0, PubMed 36944929
31. Sandberg EL, Halvorsen S, Berge T, Grimsmo J, Atar D, Fensli R, Grenne BL, Jortveit J (2023)
    Fully digital self-screening for atrial fibrillation with patch electrocardiogram
    Europace, 25 (5)
    DOI 10.1093/europace/euad075, PubMed 36945146
32. Sasi A, Romaine A, Erusappan PM, Melleby AO, Hasic A, Dahl CP, Broch K, Almaas VM, Puertas RD, Roderick HL, Lunde IG, Sjaastad I, Vistnes M, Christensen G (2023)
    Temporal expression and spatial distribution of the proteoglycan versican during cardiac fibrosis development
    Matrix Biol Plus, 19-20, 100135
    DOI 10.1016/j.mbplus.2023.100135, PubMed 38076279
33. Schneider A, Atar D, Agewall S (2023)
    RESPONSE: Climate Change and Health: Challenges, Opportunities, and the Need for Action
    J Am Coll Cardiol, 81 (11), 1130-1132
    DOI 10.1016/j.jacc.2022.10.041, PubMed 36922095
34. Semb AG, Vesterbekkmo EK, Retterstøl K, Atar D, Solberg EE, Schirmer H, Løchen ML, Kask A, Grimsmo J, Ingul CB, Munkhaugen J (2023)
    [PCSK9 inhibitors on reimbursable prescription: who is eligible?]
    Tidsskr Nor Laegeforen, 143 (8)
    DOI 10.4045/tidsskr.23.0191, PubMed 37254976
35. Serebruany VL, Tanguay JF, Gurvich ML, Marciniak TA, Atar D (2023)
    Time Course of Death After Acute Coronary Syndrome Treated With Dual Antiplatelet Therapy for 1 Year
    Am J Med, 136 (5), 484-488
    DOI 10.1016/j.amjmed.2023.01.029, PubMed 36828207
36. Serebruany VL, Tanguay JF, Gurvich ML, Marciniak TA, Atar D (2023)
    Strokes and Transient Ischemic Attacks Occurrence During Annual Dual Antiplatelet Therapy
    Am J Ther, 30 (5), e411-e415
    DOI 10.1097/MJT.0000000000001622, PubMed 37713684
37. Sundqvist MG, Sörensson P, Ekenbäck C, Lundin M, Agewall S, Brolin EB, Cederlund K, Collste O, Daniel M, Jensen J, Y-Hassan S, Henareh L, Hofman-Bang C, Lyngå P, Maret E, Sarkar N, Spaak J, Winnberg O, Caidahl K, Ugander M, Tornvall P (2023)
    CMR Is Often Abnormal Despite Normal Echocardiography in Suspected Myocardial Infarction With Nonobstructed Coronary Arteries
    JACC Cardiovasc Imaging, 16 (12), 1626-1628
    DOI 10.1016/j.jcmg.2023.05.024, PubMed 37498255
38. Sverre E, Halvorsen S, Løchen ML, Munkhaugen J (2023)
    [E. Sverre et al. respond]
    Tidsskr Nor Laegeforen, 143 (3)
    DOI 10.4045/tidsskr.23.0062, PubMed 36811436
39. Tamargo J, Agewall S, Borghi C, Ceconi C, Cerbai E, Dan GA, Ferdinandy P, Grove EL, Rocca B, Sulzgruber P, Semb AG, Sossalla S, Niessner A, Kaski JC, Dobrev D (2023)
    New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2022
    Eur Heart J Cardiovasc Pharmacother, 9 (4), 353-70 (in press)
    DOI 10.1093/ehjcvp/pvad034, PubMed 37169875
40. Tancin Lambert A, Ratajczak-Tretel B, Al-Ani R, Arntzen K, Bakkejord GK, Bekkeseth HMO, Bjerkeli V, Eldøen G, Gulsvik AK, Halvorsen B, Høie GA, Ihle-Hansen H, Ihle-Hansen H, Ingebrigtsen S, Johansen H, Kremer C, Krogseth SB, Kruuse C, Kurz M, Nakstad I, Novotny V, Naess H, Qazi R, Rezai MK, Rørholt DM et al. (2023)
    Biomarkers predictive of atrial fibrillation in patients with cryptogenic stroke. Insights from the Nordic Atrial Fibrillation and Stroke (NOR-FIB) study
    Eur J Neurol, 30 (5), 1352-1363
    DOI 10.1111/ene.15746, PubMed 36786305
41. Tjessum L, Agewall S (2023)
    Evaluation of a Structuralized Sick-Leave Programme Compared with usual Care Sick-Leave Management for Patients after an Acute Myocardial Infarction
    J Rehabil Med, 55, jrm4569
    DOI 10.2340/jrm.v55.4569, PubMed 37486246
42. Valgimigli M, Aboyans V, Angiolillo D, Atar D, Capodanno D, Halvorsen S, James S, Jüni P, Kunadian V, Landi A, Leonardi S, Mehran R, Montalescot G, Navarese EP, Niebauer J, Oliva A, Piccolo R, Price S, Storey RF, Völler H, Vranckx P, Windecker S, Fox KAA (2023)
    Antithrombotic treatment strategies in patients with established coronary atherosclerotic disease
    Eur Heart J Cardiovasc Pharmacother, 9 (5), 462-496
    DOI 10.1093/ehjcvp/pvad032, PubMed 37120728
43. Vinter N, Halminen O, Lehto M, Airaksinen KEJ, Andersson T, Wändell P, Holzmann M, Rutherford OC, Halvorsen S, Cordsen P, Frost L, Johnsen SP (2023)
    Geographical variation in persistence to oral anticoagulation therapy and clinical outcomes among patients with atrial fibrillation initiating therapy in Denmark, Sweden, Norway and Finland
    Basic Clin Pharmacol Toxicol, 133 (2), 168-178
    DOI 10.1111/bcpt.13902, PubMed 37230945
44. Vistisen D, Carstensen B, Elisabetta P, Lanzinger S, Tan EC, Yabe D, Kim DJ, Sheu WH, Melzer-Cohen C, Holl RW, Núñez J, Ha KH, Halvorsen S, Langslet G, Karasik A, Nyström T, Niskanen L, Guleria S, Klement R, Carrasco M, Foersch J, Shay C, Koeneman L, Hoti F, Farsani SF et al. (2023)
    Empagliflozin is associated with lower cardiovascular risk compared with dipeptidyl peptidase-4 inhibitors in adults with and without cardiovascular disease: EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study results from Europe and Asia
    Cardiovasc Diabetol, 22 (1), 233
    DOI 10.1186/s12933-023-01963-9, PubMed 37653496
45. Vistnes M (2023)
    How can we improve the follow-up of patients with heart failure?
    Tidsskr Nor Laegeforen, 143 (17)
    DOI 10.4045/tidsskr.23.0735, PubMed 37987060
46. Vistnes M, Erusappan PM, Sasi A, Nordén ES, Bergo KK, Romaine A, Lunde IG, Zhang L, Olsen MB, Øgaard J, Carlson CR, Wang CH, Riise J, Dahl CP, Fiane AE, Hauge-Iversen IM, Espe E, Melleby AO, Tønnessen T, Aronsen JM, Sjaastad I, Christensen G (2023)
    Inhibition of the extracellular enzyme A disintegrin and metalloprotease with thrombospondin motif 4 prevents cardiac fibrosis and dysfunction
    Cardiovasc Res, 119 (10), 1915-1927
    DOI 10.1093/cvr/cvad078, PubMed 37216909
47. Wärme J, Sundqvist MO, Hjort M, Agewall S, Collste O, Ekenbäck C, Frick M, Henareh L, Hofman-Bang C, Spaak J, Sörensson P, Y-Hassan S, Svensson P, Lindahl B, Hofmann R, Tornvall P (2023)
    Helicobacter pylori and Pro-Inflammatory Protein Biomarkers in Myocardial Infarction with and without Obstructive Coronary Artery Disease
    Int J Mol Sci, 24 (18)
    DOI 10.3390/ijms241814143, PubMed 37762446

Publications 2022

1. Agewall S (2022)
   Treatment with dual antiplatelet therapy after an acute coronary event may often be tailor-made for the patient
   Eur Heart J Cardiovasc Pharmacother, 8 (1), 1-3
   DOI 10.1093/ehjcvp/pvab078, PubMed 34984441
2. Agewall S (2022)
   Optimizing individual heart failure treatment
   Eur Heart J Cardiovasc Pharmacother, 8 (2), 105-107
   DOI 10.1093/ehjcvp/pvab087, PubMed 35039827
3. Agewall S (2022)
   New cardiology aspects of triple antithrombotic therapy, diabetes without insulin therapy as a risk factor in atrial fibrillation, treatment of gout, cholesterol lowering treatment, prostate cancer treatment, out-of-hospital cardiac arrest, Fabry disease, beta-blocker use after myocardial infarction in patients with normal ejection fraction, cardio-renal benefits of SGLT2 Inhibitors and interpretation of clinical trials
   Eur Heart J Cardiovasc Pharmacother, 8 (3), 213-215
   DOI 10.1093/ehjcvp/pvac019, PubMed 35435962
4. Agewall S (2022)
   Focus on different aspects of atrial fibrillation
   Eur Heart J Cardiovasc Pharmacother, 8 (4), 323-324
   DOI 10.1093/ehjcvp/pvac035, PubMed 35674202
5. Agewall S (2022)
   Focus on optimizing treatment of coronary heart disease
   Eur Heart J Cardiovasc Pharmacother, 8 (5), 431-433
   DOI 10.1093/ehjcvp/pvac039, PubMed 35856265
6. Agewall S (2022)
   Prevention is still the key to success
   Eur Heart J Cardiovasc Pharmacother, 8 (6), 537-538
   DOI 10.1093/ehjcvp/pvac046, PubMed 36057770
7. Agewall S (2022)
   Treating patients with anticoagulants and antiplatelet drugs is always a balance between risk for thrombosis vs. risk for bleeding
   Eur Heart J Cardiovasc Pharmacother, 8 (7), 645-647
   DOI 10.1093/ehjcvp/pvac048, PubMed 36172980
8. Agewall S (2022)
   To treat or not to treat
   Eur Heart J Cardiovasc Pharmacother, 8 (8), 754-755
   DOI 10.1093/ehjcvp/pvac062, PubMed 36458860
9. Agewall S (2022)
   Pharmacological treatment of CVD
   Eur Heart J Cardiovasc Pharmacother, 9 (1), 1-3
   DOI 10.1093/ehjcvp/pvac068, PubMed 36519600
10. Atar D, Langslet G, Tonstad S (2022)
    Do we need new lipid-lowering agents in the era of PCSK9 inhibitors? Recent advances
    Kardiol Pol, 80 (7-8), 741-749
    DOI 10.33963/KP.a2022.0117, PubMed 35521719
11. Atar D, Sarkar S, Kolev E, Mura C, Brosstad F, Theodorsen L, Westen GI, Stribolt-Halvorsen PE (2022)
    Randomized, open-label, crossover trial comparing the pharmacokinetic profile of a novel oral aspirin solution and a chewed aspirin tablet
    Int J Clin Pharmacol Ther, 60 (10), 430-438
    DOI 10.5414/CP204271, PubMed 35979901
12. Bahit MC, Vora AN, Li Z, Wojdyla DM, Thomas L, Goodman SG, Aronson R, Jordan JD, Kolls BJ, Dombrowski KE, Vinereanu D, Halvorsen S, Berwanger O, Windecker S, Mehran R, Granger CB, Alexander JH, Lopes RD (2022)
    Apixaban or Warfarin and Aspirin or Placebo After Acute Coronary Syndrome or Percutaneous Coronary Intervention in Patients With Atrial Fibrillation and Prior Stroke: A Post Hoc Analysis From the AUGUSTUS Trial
    JAMA Cardiol, 7 (7), 682-689
    DOI 10.1001/jamacardio.2022.1166, PubMed 35612866
13. Bahlmann E, Einarsen E, Cramariuc D, Pedersen ER, Rossebø AB, Midtbø H, Willems S, Gerdts E (2022)
    Prognosis in asymptomatic patients with discordantly graded aortic valve stenosis based on pressure recovery adjusted valve area
    Open Heart, 9 (2)
    DOI 10.1136/openhrt-2022-002159, PubMed 36428084
14. Birnbaum Y, Rankinen J, Jneid H, Atar D, Nikus K (2022)
    The Role of ECG in the Diagnosis and Risk Stratification of Acute Coronary Syndromes: an Old but Indispensable Tool
    Curr Cardiol Rep, 24 (2), 109-118
    DOI 10.1007/s11886-021-01628-7, PubMed 35028816
15. Blöndal M, Ainla T, Eha J, Lõiveke P, Marandi T, Saar A, Veldre G, Edfors R, Lewinter C, Jernberg T, Jortveit J, Halvorsen S, Becker D, Csanádi Z, Ferenci T, Andréka P, Jánosi A (2022)
    Comparison of management and outcomes of ST-segment elevation myocardial infarction patients in Estonia, Hungary, Norway, and Sweden according to national ongoing registries
    Eur Heart J Qual Care Clin Outcomes, 8 (3), 307-314
    DOI 10.1093/ehjqcco/qcaa098, PubMed 33710273
16. Butt JH, Dewan P, Jhund PS, Anand IS, Atar D, Ge J, Desai AS, Echeverria LE, Køber L, Lam CSP, Maggioni AP, Martinez F, Packer M, Rouleau JL, Sim D, Van Veldhuisen DJ, Vrtovec B, Zannad F, Zile MR, Gong J, Lefkowitz MP, Rizkala AR, Solomon SD, McMurray JJV (2022)
    Sacubitril/Valsartan and Frailty in Patients With Heart Failure and Preserved Ejection Fraction
    J Am Coll Cardiol, 80 (12), 1130-1143
    DOI 10.1016/j.jacc.2022.06.037, PubMed 36050227
17. De Caterina R, Agewall S, Andreotti F, Angiolillo DJ, Bhatt DL, Byrne RA, Collet JP, Eikelboom J, Fanaroff AC, Gibson CM, Goette A, Hindricks G, Lip GYH, Potpara T, Thiele H, Lopes RD, Galli M (2022)
    Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week
    Eur Heart J, 43 (37), 3512-3527
    DOI 10.1093/eurheartj/ehac294, PubMed 35925556
18. De Caterina R, Patti G, Westerbergh J, Horowitz J, Ezekowitz JA, Lewis BS, Lopes RD, McMurray JJV, Atar D, Bahit MC, Keltai M, López-Sendón JL, Ruzyllo W, Granger CB, Alexander JH, Wallentin L (2022)
    Heterogeneity of diabetes as a risk factor for major adverse cardiovascular events in anticoagulated patients with atrial fibrillation: an analysis of the ARISTOTLE trial
    Eur Heart J Cardiovasc Pharmacother, 8 (3), 227-235
    DOI 10.1093/ehjcvp/pvaa140, PubMed 33367487
19. Drexel H, Pocock SJ, Lewis BS, Saely CH, Kaski JC, Rosano GMC, Tautermann G, Huber K, Dopheide JF, Mader A, Niessner A, Savarese G, Schmidt TA, Semb AG, Tamargo J, Wassmann S, Clodi M, Kjeldsen KP, Agewall S (2022)
    Subgroup analyses in randomized clinical trials: value and limitations. Review #3 on important aspects of randomized clinical trials in cardiovascular pharmacotherapy
    Eur Heart J Cardiovasc Pharmacother, 8 (3), 302-310
    DOI 10.1093/ehjcvp/pvab048, PubMed 34180504
20. Edfors R, Jernberg T, Lewinter C, Blöndal M, Eha J, Lõiveke P, Marandi T, Ainla T, Saar A, Veldre G, Ferenci T, Andréka P, Jánosi A, Jortveit J, Halvorsen S (2022)
    Differences in characteristics, treatments and outcomes in patients with non-ST-elevation myocardial infarction: novel insights from four national European continuous real-world registries
    Eur Heart J Qual Care Clin Outcomes, 8 (4), 429-436
    DOI 10.1093/ehjqcco/qcab013, PubMed 33605415
21. El Hadidi S, Rosano G, Tamargo J, Agewall S, Drexel H, Kaski JC, Niessner A, Lewis BS, Coats AJS, Savarese G (2022)
    Potentially inappropriate prescriptions in heart failure with reduced ejection fraction: ESC position statement on heart failure with reduced ejection fraction-specific inappropriate prescribing
    Eur Heart J Cardiovasc Pharmacother, 8 (2), 187-210
    DOI 10.1093/ehjcvp/pvaa108, PubMed 32941594
22. Engebretsen I, Munkhaugen J, Bugge C, Halvorsen S, Ødegaard KM, Støvring H, Kristiansen IS (2022)
    Gaps and discontinuation of statin treatment in Norway: potential for optimizing management of lipid lowering drugs
    Eur Heart J Open, 2 (6), oeac070
    DOI 10.1093/ehjopen/oeac070, PubMed 36440353
23. Fyksen TS, Vanberg P, Gjesdal K, von Lueder TG, Bjørnerheim R, Steine K, Atar D, Halvorsen S (2022)
    Cardiovascular phenotype of long-term anabolic-androgenic steroid abusers compared with strength-trained athletes
    Scand J Med Sci Sports, 32 (8), 1170-1181
    DOI 10.1111/sms.14172, PubMed 35460300
24. Gevaert SA, Halvorsen S, Sinnaeve PR, Sambola A, Gulati G, Lancellotti P, Van Der Meer P, Lyon AR, Farmakis D, Lee G, Boriani G, Wechalekar A, Okines A, Asteggiano R, Combes A, Pfister R, Bergler-Klein J, Lettino M (2022)
    Evaluation and management of cancer patients presenting with acute cardiovascular disease: a Clinical Consensus Statement of the Acute CardioVascular Care Association (ACVC) and the ESC council of Cardio-Oncology-part 2: acute heart failure, acute myocardial diseases, acute venous thromboembolic diseases, and acute arrhythmias
    Eur Heart J Acute Cardiovasc Care, 11 (11), 865-874
    DOI 10.1093/ehjacc/zuac107, PubMed 36226746
25. Gløersen M, Steen Pettersen P, Neogi T, Jafarzadeh SR, Vistnes M, Thudium CS, Bay-Jensen AC, Sexton J, Kvien TK, Hammer HB, Haugen IK (2022)
    Associations of Body Mass Index With Pain and the Mediating Role of Inflammatory Biomarkers in People With Hand Osteoarthritis
    Arthritis Rheumatol, 74 (5), 810-817
    DOI 10.1002/art.42056, PubMed 35137553
26. Gulati G (2022)
    Cardioprotection in breast cancer patients: one size fits all?
    Eur Heart J, 43 (27), 2570-2572
    DOI 10.1093/eurheartj/ehab810, PubMed 34951626
27. Gulati G, Tjessem KH, Horndalsveen H, Halvorsen S, Haakensen VD (2022)
    [Checkpoint inhibitor-induced myocarditis]
    Tidsskr Nor Laegeforen, 142 (18)
    DOI 10.4045/tidsskr.21.0817, PubMed 36511752
28. Hadziselimovic E, Greve AM, Sajadieh A, Olsen MH, Kesäniemi YA, Nienaber CA, Ray SG, Rossebø AB, Willenheimer R, Wachtell K, Nielsen OW (2022)
    Association of Annual N-Terminal Pro-Brain Natriuretic Peptide Measurements With Clinical Events in Patients With Asymptomatic Nonsevere Aortic Stenosis: A Post Hoc Substudy of the SEAS Trial
    JAMA Cardiol, 7 (4), 435-444
    DOI 10.1001/jamacardio.2021.5916, PubMed 35171199
29. Hall TS, Ørn S, Zannad F, Rossignol P, Duarte K, Solomon SD, Atar D, Agewall S, Dickstein K, Girerd N (2022)
    The Association of Smoking with Hospitalization and Mortality Differs According to Sex in Patients with Heart Failure Following Myocardial Infarction
    J Womens Health (Larchmt), 31 (3), 310-320
    DOI 10.1089/jwh.2021.0326, PubMed 35049355
30. Halvorsen S, Johnsen SP, Madsen M, Linder M, Sulo G, Ghanima W, Gislason G, Hohnloser SH, Jenkins A, Al-Khalili F, Tell GS, Ehrenstein V (2022)
    Effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in atrial fibrillation: a Scandinavian population-based cohort study
    Eur Heart J Qual Care Clin Outcomes, 8 (5), 577-587
    DOI 10.1093/ehjqcco/qcab048, PubMed 34244745
31. Halvorsen S, Smith JA, Söderdahl F, Thuresson M, Solli O, Ulvestad M, Jonasson C (2022)
    Changes in primary care management of atrial fibrillation patients following the shift from warfarin to non-vitamin K antagonist oral anticoagulants: a Norwegian population based study
    BMC Prim Care, 23 (1), 214
    DOI 10.1186/s12875-022-01824-6, PubMed 36008778
32. Heiberg E, Engblom H, Carlsson M, Erlinge D, Atar D, Aletras AH, Arheden H (2022)
    Infarct quantification with cardiovascular magnetic resonance using "standard deviation from remote" is unreliable: validation in multi-centre multi-vendor data
    J Cardiovasc Magn Reson, 24 (1), 53
    DOI 10.1186/s12968-022-00888-8, PubMed 36336693
33. Hellgren T, Blöndal M, Jortveit J, Ferenci T, Faxén J, Lewinter C, Eha J, Lõiveke P, Marandi T, Ainla T, Saar A, Veldre G, Andréka P, Halvorsen S, Jánosi A, Edfors R (2022)
    Sex-related differences in the management and outcomes of patients hospitalized with ST-elevation myocardial infarction: a comparison within four European myocardial infarction registries
    Eur Heart J Open, 2 (4), oeac042
    DOI 10.1093/ehjopen/oeac042, PubMed 35919580
34. Hokstad I, Greco D, Deyab G, Fagerland MW, Agewall S, Hjeltnes G, Zimetti F, Bernini F, Ronda N, Hollan I (2022)
    Effects of Antirheumatic Treatment on Cell Cholesterol Efflux and Loading Capacity of Serum Lipoproteins in Spondylarthropathies
    J Clin Med, 11 (24)
    DOI 10.3390/jcm11247330, PubMed 36555946
35. Johannessen TR, Halvorsen S, Atar D, Munkhaugen J, Nore AK, Wisløff T, Vallersnes OM (2022)
    Cost-effectiveness of a rule-out algorithm of acute myocardial infarction in low-risk patients: emergency primary care versus hospital setting
    BMC Health Serv Res, 22 (1), 1274
    DOI 10.1186/s12913-022-08697-6, PubMed 36271364
36. Johannessen TR, Halvorsen S, Atar D, Vallersnes OM (2022)
    Performance of the Novel Observation Group Criteria of the European Society of Cardiology (ESC) 0/1-Hour Algorithm in a Low-Risk Population
    J Am Heart Assoc, 11 (7), e024927
    DOI 10.1161/JAHA.121.024927, PubMed 35352564
37. Jortveit J, Pripp AH, Langørgen J, Halvorsen S (2022)
    Time trends in incidence, treatment, and outcome in acute myocardial infarction in Norway 2013-19
    Eur Heart J Open, 2 (5), oeac052
    DOI 10.1093/ehjopen/oeac052, PubMed 36071696
38. Jortveit J, Sandberg EL, Pripp AH, Halvorsen S (2022)
    Time trends in adherence to guideline recommendations for anticoagulation therapy in patients with atrial fibrillation and myocardial infarction
    Open Heart, 9 (1)
    DOI 10.1136/openhrt-2021-001934, PubMed 35387862
39. Kluge KE, Langseth MS, Andersen GØ, Halvorsen S, Opstad TB, Arnesen H, Tønnessen T, Seljeflot I, Helseth R (2022)
    Complement activation in association with clinical outcomes in ST-elevation myocardial infarction
    Am Heart J Plus, 24, 100228
    DOI 10.1016/j.ahjo.2022.100228, PubMed 38560636
40. Kluge KE, Seljeflot I, Arnesen H, Jensen T, Halvorsen S, Helseth R (2022)
    Coagulation factors XI and XII as possible targets for anticoagulant therapy
    Thromb Res, 214, 53-62
    DOI 10.1016/j.thromres.2022.04.013, PubMed 35490644
41. Komiyama M, Agewall S, Hasegawa K (2022)
    Future of antithrombotic therapy for heart failure with coronary artery disease
    Eur Heart J Cardiovasc Pharmacother, 8 (5), e25
    DOI 10.1093/ehjcvp/pvac030, PubMed 35521703
42. Korthauer LE, Giugliano RP, Guo J, Sabatine MS, Sever P, Keech A, Atar D, Kurtz C, Ruff CT, Mach F, Ott BR (2022)
    No association between APOE genotype and lipid lowering with cognitive function in a randomized controlled trial of evolocumab
    PLoS One, 17 (4), e0266615
    DOI 10.1371/journal.pone.0266615, PubMed 35404972
43. Kotecha D, Asselbergs FW, Achenbach S, Anker SD, Atar D, Baigent C, Banerjee A, Beger B, Brobert G, Casadei B, Ceccarelli C, Cowie MR, Crea F, Cronin M, Denaxas S, Derix A, Fitzsimons D, Fredriksson M, Gale CP, Gkoutos GV, Goettsch W, Hemingway H, Ingvar M, Jonas A, Kazmierski R et al. (2022)
    CODE-EHR best-practice framework for the use of structured electronic health-care records in clinical research
    Lancet Digit Health, 4 (10), e757-e764
    DOI 10.1016/S2589-7500(22)00151-0, PubMed 36050271
44. Kotecha D, Asselbergs FW, Achenbach S, Anker SD, Atar D, Baigent C, Banerjee A, Beger B, Brobert G, Casadei B, Ceccarelli C, Cowie MR, Crea F, Cronin M, Denaxas S, Derix A, Fitzsimons D, Fredriksson M, Gale CP, Gkoutos GV, Goettsch W, Hemingway H, Ingvar M, Jonas A, Kazmierski R et al. (2022)
    CODE-EHR best practice framework for the use of structured electronic healthcare records in clinical research
    BMJ, 378, e069048
    DOI 10.1136/bmj-2021-069048, PubMed 36562446
45. Kotecha D, Asselbergs FW, Achenbach S, Anker SD, Atar D, Baigent C, Banerjee A, Beger B, Brobert G, Casadei B, Ceccarelli C, Cowie MR, Crea F, Cronin M, Denaxas S, Derix A, Fitzsimons D, Fredriksson M, Gale CP, Gkoutos GV, Goettsch W, Hemingway H, Ingvar M, Jonas A, Kazmierski R et al. (2022)
    CODE-EHR best practice framework for the use of structured electronic healthcare records in clinical research
    Eur Heart J, 43 (37), 3578-3588
    DOI 10.1093/eurheartj/ehac426, PubMed 36208161
46. Krychtiuk KA, Ahrens I, Drexel H, Halvorsen S, Hassager C, Huber K, Kurpas D, Niessner A, Schiele F, Semb AG, Sionis A, Claeys MJ, Barrabes J, Montero S, Sinnaeve P, Pedretti R, Catapano A (2022)
    Acute LDL-C reduction post ACS: strike early and strike strong: from evidence to clinical practice. A clinical consensus statement of the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Association of Preventive Cardiology (EAPC) and the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
    Eur Heart J Acute Cardiovasc Care, 11 (12), 939-949
    DOI 10.1093/ehjacc/zuac123, PubMed 36574353
47. Magavern EF, Kaski JC, Turner RM, Drexel H, Janmohamed A, Scourfield A, Burrage D, Floyd CN, Adeyeye E, Tamargo J, Lewis BS, Kjeldsen KP, Niessner A, Wassmann S, Sulzgruber P, Borry P, Agewall S, Semb AG, Savarese G, Pirmohamed M, Caulfield MJ (2022)
    The role of pharmacogenomics in contemporary cardiovascular therapy: a position statement from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
    Eur Heart J Cardiovasc Pharmacother, 8 (1), 85-99
    DOI 10.1093/ehjcvp/pvab018, PubMed 33638977
48. Magavern EF, Kaski JC, Turner RM, Drexel H, Janmohamed A, Scourfield A, Burrage D, Floyd CN, Adeyeye E, Tamargo J, Lewis BS, Kjeldsen KP, Niessner A, Wassmann S, Sulzgruber P, Borry P, Agewall S, Semb AG, Savarese G, Pirmohamed M, Caulfield MJ (2022)
    Challenges in cardiovascular pharmacogenomics implementation: a viewpoint from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
    Eur Heart J Cardiovasc Pharmacother, 8 (1), 100-103
    DOI 10.1093/ehjcvp/pvab063, PubMed 34463331
49. Martínez-Montesinos L, Rivera-Caravaca JM, Agewall S, Soler E, Lip GYH, Marín F, Roldán V (2022)
    Polypharmacy and adverse events in atrial fibrillation: Main cause or reflection of multimorbidity?
    Biomed Pharmacother, 158, 114064
    DOI 10.1016/j.biopha.2022.114064, PubMed 36495662
50. Moschetti K, Kwong RY, Petersen SE, Lombardi M, Garot J, Atar D, Rademakers FE, Sierra-Galan LM, Mavrogeni S, Li K, Fernandes JL, Schneider S, Pinget C, Ge Y, Antiochos P, Deluigi C, Bruder O, Mahrholdt H, Schwitter J (2022)
    Cost-Minimization Analysis for Cardiac Revascularization in 12 Health Care Systems Based on the EuroCMR/SPINS Registries
    JACC Cardiovasc Imaging, 15 (4), 607-625
    DOI 10.1016/j.jcmg.2021.11.008, PubMed 35033498
51. Nguyen THP, Hokstad I, Fagerland MW, Mollnes TE, Hollan I, Feinberg MW, Hjeltnes G, Eilertsen GØ, Mikkelsen K, Agewall S (2022)
    Antirheumatic therapy is associated with reduced complement activation in rheumatoid arthritis
    PLoS One, 17 (2), e0264628
    DOI 10.1371/journal.pone.0264628, PubMed 35213675
52. Nickander J, Ekenbäck C, Agewall S, Bacsovics Brolin E, Caidahl K, Cederlund K, Collste O, Daniel M, Jensen J, Y-Hassan S, Henareh L, Hofman-Bang C, Lyngå P, Maret E, Sarkar N, Spaak J, Winnberg O, Sundqvist M, Ugander M, Tornvall P, Sörensson P (2022)
    Comprehensive Follow-Up Cardiac Magnetic Resonance of Patients With Myocardial Infarction With Nonobstructive Coronary Arteries
    JACC Cardiovasc Imaging, 16 (1), 128-129
    DOI 10.1016/j.jcmg.2022.07.021, PubMed 36599558
53. Nordeng J, Solheim S, Åkra S, Schandiz H, Hoffmann P, Roald B, Bendz B, Arnesen H, Helseth R, Seljeflot I (2022)
    Gene expression of fibrinolytic markers in coronary thrombi
    Thromb J, 20 (1), 23
    DOI 10.1186/s12959-022-00383-1, PubMed 35488283
54. O'Donoghue ML, Giugliano RP, Wiviott SD, Atar D, Keech A, Kuder JF, Im K, Murphy SA, Flores-Arredondo JH, López JAG, Elliott-Davey M, Wang B, Monsalvo ML, Abbasi S, Sabatine MS (2022)
    Long-Term Evolocumab in Patients With Established Atherosclerotic Cardiovascular Disease
    Circulation, 146 (15), 1109-1119
    DOI 10.1161/CIRCULATIONAHA.122.061620, PubMed 36031810
55. Omland T, Heck SL, Gulati G (2022)
    The Role of Cardioprotection in Cancer Therapy Cardiotoxicity: JACC: CardioOncology State-of-the-Art Review
    JACC CardioOncol, 4 (1), 19-37
    DOI 10.1016/j.jaccao.2022.01.101, PubMed 35492815
56. Ratajczak-Tretel B, Lambert AT, Atar D, Aamodt AH (2022)
    Cryptogenic stroke and TIA: Suggested diagnostic approach while waiting for evaluation and treatment guidelines
    Acta Neurol Scand, 145 (5), 641-646
    DOI 10.1111/ane.13590, PubMed 35146751
57. Ratajczak-Tretel B, Tancin Lambert A, Al-Ani R, Arntzen K, Bakkejord GK, Bekkeseth H, Bjerkeli V, Eldøen G, Gulsvik A, Halvorsen B, Høie GA, Ihle-Hansen H, Ihle-Hansen H, Ingebrigtsen S, Johansen H, Kremer C, Krogseth SB, Kruuse C, Kurz M, Nakstad I, Novotny V, Næss H, Qazi R, Rezaj MK, Rørholt DM et al. (2022)
    Atrial fibrillation in cryptogenic stroke and TIA patients in The Nordic Atrial Fibrillation and Stroke (NOR-FIB) Study: Main results
    Eur Stroke J, 8 (1), 148-156
    DOI 10.1177/23969873221123122, PubMed 37021182
58. Saldarriaga C, Atar D, Stebbins A, Lewis BS, Abidin IZ, Blaustein RO, Butler J, Ezekowitz JA, Hernandez AF, Lam CSP, O'Connor CM, Pieske B, Ponikowski P, Roessig L, Voors AA, Anstrom KJ, Armstrong PW, VICTORIA Study Group (2022)
    Vericiguat in patients with coronary artery disease and heart failure with reduced ejection fraction
    Eur J Heart Fail, 24 (5), 782-790
    DOI 10.1002/ejhf.2468, PubMed 35239245
59. Serebruany VL, Tanguay JF, Kuliczkowski W, Heidel E, Kim MH, Atar D (2022)
    Impact of Bleeding on Myocardial Infarction, Stroke, and Death During 12 Months Dual Antiplatelet Therapy After Acute Coronary Syndrome
    Am J Med, 135 (11), 1342-1348
    DOI 10.1016/j.amjmed.2022.07.022, PubMed 35977606
60. Sverre E, Halvorsen S, Løchen ML, Munkhaugen J (2022)
    Personalised cardiovascular disease prevention in the new guidelines
    Tidsskr Nor Laegeforen, 142 (17)
    DOI 10.4045/tidsskr.22.0508, PubMed 36416647
61. Tamargo J, Hasegawa K, Agewall S (2022)
    Toward personalized medicine for cardiovascular pharmacotherapy
    Eur Heart J, 43 (45), 4719-4721
    DOI 10.1093/eurheartj/ehac413, PubMed 35924414
62. Tamargo J, Kaski JC, Kimura T, Barton JC, Yamamoto K, Komiyama M, Drexel H, Lewis BS, Agewall S, Hasegawa K (2022)
    Racial and ethnic differences in pharmacotherapy to prevent coronary artery disease and thrombotic events
    Eur Heart J Cardiovasc Pharmacother, 8 (7), 738-751
    DOI 10.1093/ehjcvp/pvac040, PubMed 35848895
63. Tamargo J, Kjeldsen KP, Delpón E, Semb AG, Cerbai E, Dobrev D, Savarese G, Sulzgruber P, Rosano G, Borghi C, Wassmann S, Torp-Pedersen CT, Agewall S, Drexel H, Baumgartner I, Lewis B, Ceconi C, Kaski JC, Niessner A (2022)
    Facing the challenge of polypharmacy when prescribing for older people with cardiovascular disease. A review by the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
    Eur Heart J Cardiovasc Pharmacother, 8 (4), 406-419
    DOI 10.1093/ehjcvp/pvac005, PubMed 35092425
64. Task Force for the management of COVID-19 of the European Society of Cardiology, Baigent C, Windecker S, Andreini D, Arbelo E, Barbato E, Bartorelli AL, Baumbach A, Behr ER, Berti S, Bueno H, Capodanno D, Cappato R, Chieffo A, Collet JP, Cuisset T, de Simone G, Delgado V, Dendale P, Dudek D, Edvardsen T, Elvan A, González-Juanatey JR, Gori M, Grobbee D et al. (2022)
    European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis
    Cardiovasc Res, 118 (6), 1385-1412
    DOI 10.1093/cvr/cvab342, PubMed 34864874
65. Thind M, Zareba W, Atar D, Crijns HJGM, Zhu J, Pak HN, Reiffel J, Ludwigs U, Wieloch M, Stewart J, Kowey P (2022)
    Efficacy and safety of dronedarone versus placebo in patients with atrial fibrillation stratified according to renal function: Post hoc analyses of the EURIDIS-ADONIS trials
    Clin Cardiol, 45 (1), 101-109
    DOI 10.1002/clc.23765, PubMed 35019175
66. Triska J, Maitra N, Deshotels MR, Haddadin F, Angiolillo DJ, Vilahur G, Jneid H, Atar D, Birnbaum Y (2022)
    A Comprehensive Review of the Pleiotropic Effects of Ticagrelor
    Cardiovasc Drugs Ther, 38 (4), 775-797
    DOI 10.1007/s10557-022-07373-5, PubMed 36001200
67. van der Meer D, Gurholt TP, Sønderby IE, Shadrin AA, Hindley G, Rahman Z, de Lange AG, Frei O, Leinhard OD, Linge J, Simon R, Beck D, Westlye LT, Halvorsen S, Dale AM, Karlsen TH, Kaufmann T, Andreassen OA (2022)
    The link between liver fat and cardiometabolic diseases is highlighted by genome-wide association study of MRI-derived measures of body composition
    Commun Biol, 5 (1), 1271
    DOI 10.1038/s42003-022-04237-4, PubMed 36402844
68. Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, Benetos A, Biffi A, Boavida JM, Capodanno D, Cosyns B, Crawford C, Davos CH, Desormais I, Angelantonio ED, Franco OH, Halvorsen S, Richard Hobbs FD, Hollander M, Jankowska EA, Michal M, Sacco S, Sattar N, Tokgozoglu L, Tonstad S et al. (2022)
    2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC)
    Rev Esp Cardiol (Engl Ed), 75 (5), 429
    DOI 10.1016/j.rec.2022.04.003, PubMed 35525570
69. Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, Benetos A, Biffi A, Boavida JM, Capodanno D, Cosyns B, Crawford C, Davos CH, Desormais I, Di Angelantonio E, Franco OH, Halvorsen S, Hobbs FDR, Hollander M, Jankowska EA, Michal M, Sacco S, Sattar N, Tokgozoglu L, Tonstad S et al. (2022)
    2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
    Eur J Prev Cardiol, 29 (1), 5-115
    DOI 10.1093/eurjpc/zwab154, PubMed 34558602
70. Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, Benetos A, Biffi A, Boavida JM, Capodanno D, Cosyns B, Crawford C, Davos CH, Desormais I, Di Angelantonio E, Franco OH, Halvorsen S, Hobbs FDR, Hollander M, Jankowska EA, Michal M, Sacco S, Sattar N, Tokgozoglu L, Tonstad S et al. (2022)
    [2021 ESC Guidelines on cardiovascular disease prevention in clinical practice]
    G Ital Cardiol (Rome), 23 (6 Suppl 1), e3-e115
    DOI 10.1714/3808.37926, PubMed 35708476
71. von Kemp B, Halvorsen S, Nohria A (2022)
    The new 2022 ESC Guidelines on Cardio-oncology and their impact on the Acute Cardiovascular Care Society
    Eur Heart J Acute Cardiovasc Care, 11 (11), 844-849
    DOI 10.1093/ehjacc/zuac129, PubMed 36205095
72. Welsh RC, Dehghani P, Lopes R, Wojdyla DM, Aronson R, Granger CB, Windecker S, Vora AN, Vinereanu D, Halvorsen S, Parkhomenko A, Mehran R, Alexander JH, Goodman S (2022)
    Impact of prior oral anticoagulant use and outcomes on patients from secondary analysis in the AUGUSTUS trial
    Open Heart, 9 (1)
    DOI 10.1136/openhrt-2021-001892, PubMed 35172988
73. Ye R, Jneid H, Alam M, Uretsky BF, Atar D, Kitakaze M, Davidson SM, Yellon DM, Birnbaum Y (2022)
    Do We Really Need Aspirin Loading for STEMI?
    Cardiovasc Drugs Ther, 36 (6), 1221-1238
    DOI 10.1007/s10557-022-07327-x, PubMed 35171384
74. Ødegaard KM, Lirhus SS, Melberg HO, Hallén J, Halvorsen S (2022)
    A nationwide registry study on heart failure in Norway from 2008 to 2018: variations in lookback period affect incidence estimates
    BMC Cardiovasc Disord, 22 (1), 88
    DOI 10.1186/s12872-022-02522-y, PubMed 35247979
75. Ødegaard KM, Lirhus SS, Melberg HO, Hallén J, Halvorsen S (2022)
    Adherence and persistence to pharmacotherapy in patients with heart failure: a nationwide cohort study, 2014-2020
    ESC Heart Fail, 10 (1), 405-415
    DOI 10.1002/ehf2.14206, PubMed 36266969

Publications 2021

1. Agewall S (2021)
   Atrial fibrillation in registries
   Eur Heart J Cardiovasc Pharmacother, 7 (1), 1-2
   DOI 10.1093/ehjcvp/pvaa142, PubMed 33367509
2. Agewall S (2021)
   Antiplatelet treatment in coronary syndrome
   Eur Heart J Cardiovasc Pharmacother, 7 (2), 81-82
   DOI 10.1093/ehjcvp/pvab015, PubMed 33720341
3. Agewall S (2021)
   Different aspects of giving the optimal antiplatelet treatment
   Eur Heart J Cardiovasc Pharmacother, 7 (3), 169-170
   DOI 10.1093/ehjcvp/pvab037, PubMed 34023878
4. Agewall S (2021)
   Adherence to pharmacological treatment: how can we improve?
   Eur Heart J Cardiovasc Pharmacother, 7 (4), 261-262
   DOI 10.1093/ehjcvp/pvab049, PubMed 34298551
5. Agewall S (2021)
   More knowledge about atrial fibrillation, still we need to learn
   Eur Heart J Cardiovasc Pharmacother, 7 (5), 361-362
   DOI 10.1093/ehjcvp/pvab067, PubMed 34545933
6. Agewall S (2021)
   Unsolved pharmacological issues with cardiology
   Eur Heart J Cardiovasc Pharmacother, 7 (6), 461-462
   DOI 10.1093/ehjcvp/pvab077, PubMed 34734246
7. Allahham M, Lerman A, Atar D, Birnbaum Y (2021)
   Why Not Dipyridamole: a Review of Current Guidelines and Re-evaluation of Utility in the Modern Era
   Cardiovasc Drugs Ther, 36 (3), 525-532
   DOI 10.1007/s10557-021-07224-9, PubMed 34245446
8. Atar D, Jukema JW, Molemans B, Taub PR, Goto S, Mach F, CerezoOlmos C, Underberg J, Keech A, Tokgözoğlu L, Bonaca MP (2021)
   New cardiovascular prevention guidelines: How to optimally manage dyslipidaemia and cardiovascular risk in 2021 in patients needing secondary prevention?
   Atherosclerosis, 319, 51-61
   DOI 10.1016/j.atherosclerosis.2020.12.013, PubMed 33476944
9. Awoyemi A, Mayerhofer C, Felix AS, Hov JR, Moscavitch SD, Lappegård KT, Hovland A, Halvorsen S, Halvorsen B, Gregersen I, Svardal A, Berge RK, Hansen SH, Götz A, Holm K, Aukrust P, Åkra S, Seljeflot I, Solheim S, Lorenzo A, Gullestad L, Trøseid M, Broch K (2021)
   Rifaximin or Saccharomyces boulardii in heart failure with reduced ejection fraction: Results from the randomized GutHeart trial
   EBioMedicine, 70, 103511
   DOI 10.1016/j.ebiom.2021.103511, PubMed 34329947
10. Bahlmann E, Einarsen E, Cramariuc D, Midtbø H, Mancusi C, Rossebø A, Willems S, Gerdts E (2021)
    Low myocardial energetic efficiency is associated with increased mortality in aortic stenosis
    Open Heart, 8 (2)
    DOI 10.1136/openhrt-2021-001720, PubMed 34426527
11. Birnbaum Y, Nikus K, Atar D, Jneid H (2021)
    Is RBBB the new LBBB? Are we going to repeat the same mistakes?
    J Electrocardiol, 65, 34-36
    DOI 10.1016/j.jelectrocard.2020.12.010, PubMed 33477070
12. Blichfeldt-AEro SC, Halvorsen S, Trondalen G (2021)
    Music therapy in invasive cardiac procedures: Expanded perspective
    BRIT. J. MUSIC THER., 13594575211039090
    DOI 10.1177/13594575211039090
13. Camm AJ, Atar D (2021)
    Use of Non-vitamin K Antagonist Oral Anticoagulants for Stroke Prevention across the Stroke Spectrum: Progress and Prospects
    Thromb Haemost, 121 (6), 716-730
    DOI 10.1055/s-0040-1721665, PubMed 33412613
14. Chiang CH, Chiang CH, Pickering JW, Stoyanov KM, Chew DP, Neumann JT, Ojeda F, Sörensen NA, Su KY, Kavsak P, Worster A, Inoue K, Johannessen TR, Atar D, Amann M, Hochholzer W, Mokhtari A, Ekelund U, Twerenbold R, Mueller C, Bahrmann P, Buttinger N, Dooley M, Ruangsomboon O, Nowak RM et al. (2021)
    Performance of the European Society of Cardiology 0/1-Hour, 0/2-Hour, and 0/3-Hour Algorithms for Rapid Triage of Acute Myocardial Infarction : An International Collaborative Meta-analysis
    Ann Intern Med, 175 (1), 101-113
    DOI 10.7326/M21-1499, PubMed 34807719
15. Chieffo A, Dudek D, Hassager C, Combes A, Gramegna M, Halvorsen S, Huber K, Kunadian V, Maly J, Møller JE, Pappalardo F, Tarantini G, Tavazzi G, Thiele H, Vandenbriele C, Van Mieghem N, Vranckx P, Werner N, Price S (2021)
    Joint EAPCI/ACVC expert consensus document on percutaneous ventricular assist devices
    EuroIntervention, 17 (4), e274-e286
    DOI 10.4244/EIJY21M05_01, PubMed 34057071
16. Chieffo A, Dudek D, Hassager C, Combes A, Gramegna M, Halvorsen S, Huber K, Kunadian V, Maly J, Møller JE, Pappalardo F, Tarantini G, Tavazzi G, Thiele H, Vandenbriele C, van Mieghem N, Vranckx P, Werner N, Price S (2021)
    Joint EAPCI/ACVC expert consensus document on percutaneous ventricular assist devices
    Eur Heart J Acute Cardiovasc Care, 10 (5), 570-583
    DOI 10.1093/ehjacc/zuab015, PubMed 34057173
17. Deyab G, Reine TM, Vuong TT, Jenssen T, Hjeltnes G, Agewall S, Mikkelsen K, Førre Ø, Fagerland MW, Kolset SO, Hollan I (2021)
    Antirheumatic treatment is associated with reduced serum Syndecan-1 in Rheumatoid Arthritis
    PLoS One, 16 (7), e0253247
    DOI 10.1371/journal.pone.0253247, PubMed 34242246
18. Drexel H, Lewis BS, Rosano GMC, Saely CH, Tautermann G, Huber K, Dopheide JF, Kaski JC, Mader A, Niessner A, Savarese G, Schmidt TA, Semb A, Tamargo J, Wassmann S, Per Kjeldsen K, Agewall S, Pocock SJ (2021)
    The age of randomized clinical trials: three important aspects of randomized clinical trials in cardiovascular pharmacotherapy with examples from lipid, diabetes, and antithrombotic trials
    Eur Heart J Cardiovasc Pharmacother, 7 (5), 453-459
    DOI 10.1093/ehjcvp/pvaa126, PubMed 33135079
19. Gevaert SA, Halvorsen S, Sinnaeve PR, Sambola A, Gulati G, Lancellotti P, Van Der Meer P, Lyon AR, Farmakis D, Lee G, Boriani G, Wechalekar A, Okines A, Asteggiano R (2021)
    Evaluation and management of cancer patients presenting with acute cardiovascular disease: a Consensus Document of the Acute CardioVascular Care (ACVC) association and the ESC council of Cardio-Oncology-Part 1: acute coronary syndromes and acute pericardial diseases
    Eur Heart J Acute Cardiovasc Care, 10 (8), 947-959
    DOI 10.1093/ehjacc/zuab056, PubMed 34453829
20. Ghanima W, Schultze A, Donaldson R, Brodin E, Halvorsen S, Graham S, Carroll R, Ulvestad M, Lambrelli D (2021)
    Oral Anticoagulation Therapy for Venous Thromboembolism in Norway: Time Trends and Treatment Patterns
    Clin Ther, 43 (7), 1179-1190.e3
    DOI 10.1016/j.clinthera.2021.04.017, PubMed 34083030
21. Gonzales RA, Seemann F, Lamy J, Mojibian H, Atar D, Erlinge D, Steding-Ehrenborg K, Arheden H, Hu C, Onofrey JA, Peters DC, Heiberg E (2021)
    MVnet: automated time-resolved tracking of the mitral valve plane in CMR long-axis cine images with residual neural networks: a multi-center, multi-vendor study
    J Cardiovasc Magn Reson, 23 (1), 137
    DOI 10.1186/s12968-021-00824-2, PubMed 34857009
22. Gorog DA, Price S, Sibbing D, Baumbach A, Capodanno D, Gigante B, Halvorsen S, Huber K, Lettino M, Leonardi S, Morais J, Rubboli A, Siller-Matula JM, Storey RF, Vranckx P, Rocca B (2021)
    Antithrombotic therapy in patients with acute coronary syndrome complicated by cardiogenic shock or out-of-hospital cardiac arrest: a joint position paper from the European Society of Cardiology (ESC) Working Group on Thrombosis, in association with the Acute Cardiovascular Care Association (ACCA) and European Association of Percutaneous Cardiovascular Interventions (EAPCI)
    Eur Heart J Cardiovasc Pharmacother, 7 (2), 125-140
    DOI 10.1093/ehjcvp/pvaa009, PubMed 32049278
23. Hall TS, Atar D (2021)
    The Times They Are A-Changin´: Antithrombotic strategies in patients with acute coronary syndrome undergoing coronary stenting who have concomitant atrial fibrillation
    Eur J Intern Med, 88, 21-22
    DOI 10.1016/j.ejim.2021.04.008, PubMed 33934970
24. Heck SL, Mecinaj A, Ree AH, Hoffmann P, Schulz-Menger J, Fagerland MW, Gravdehaug B, Røsjø H, Steine K, Geisler J, Gulati G, Omland T (2021)
    Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy (PRADA): Extended Follow-Up of a 2×2 Factorial, Randomized, Placebo-Controlled, Double-Blind Clinical Trial of Candesartan and Metoprolol
    Circulation, 143 (25), 2431-2440
    DOI 10.1161/CIRCULATIONAHA.121.054698, PubMed 33993702
25. Hijazi Z, Alexander JH, Li Z, Wojdyla DM, Mehran R, Granger CB, Parkhomenko A, Bahit MC, Windecker S, Aronson R, Berwanger O, Halvorsen S, de Waha-Thiele S, Sinnaeve P, Darius H, Storey RF, Lopes RD (2021)
    Apixaban or Vitamin K Antagonists and Aspirin or Placebo According to Kidney Function in Patients With Atrial Fibrillation After Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial
    Circulation, 143 (12), 1215-1223
    DOI 10.1161/CIRCULATIONAHA.120.051020, PubMed 33461308
26. Johannessen TR, Atar D, Vallersnes OM, Larstorp ACK, Mdala I, Halvorsen S (2021)
    Comparison of a single high-sensitivity cardiac troponin T measurement with the HEART score for rapid rule-out of acute myocardial infarction in a primary care emergency setting: a cohort study
    BMJ Open, 11 (2), e046024
    DOI 10.1136/bmjopen-2020-046024, PubMed 33627355
27. Krogager ML, Kragholm K, Thomassen JQ, Søgaard P, Lewis BS, Wassmann S, Baumgartner I, Ceconi C, Schmidt TA, Kaski JC, Drexel H, Semb AG, Agewall S, Niessner A, Savarese G, Kjeldsen KP, Borghi C, Tamargo J, Torp-Pedersen C (2021)
    Update on management of hypokalaemia and goals for the lower potassium level in patients with cardiovascular disease: a review in collaboration with the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
    Eur Heart J Cardiovasc Pharmacother, 7 (6), 557-567
    DOI 10.1093/ehjcvp/pvab038, PubMed 33956964
28. Krychtiuk KA, Speidl WS, Giannitsis E, Gigante B, Gorog DA, Jaffe AS, Mair J, Möckel M, Mueller C, Storey RF, Vilahur G, Wojta J, Huber K, Halvorsen S, Geisler T, Morais J, Lindahl B, Thygesen K (2021)
    Biomarkers of coagulation and fibrinolysis in acute myocardial infarction: a joint position paper of the Association for Acute CardioVascular Care and the European Society of Cardiology Working Group on Thrombosis
    Eur Heart J Acute Cardiovasc Care, 10 (3), 343-355
    DOI 10.1093/ehjacc/zuaa025, PubMed 33620437
29. Maqsood MH, Alam M, Atar D, Birnbaum Y (2021)
    Efficacy of Long-Term Oral Beta-Blocker Therapy in Patients Who Underwent Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction With Preserved Left Ventricular Ejection Fraction: A Systematic Review and Meta-analysis
    J Cardiovasc Pharmacol, 77 (1), 87-93
    DOI 10.1097/FJC.0000000000000922, PubMed 33136764
30. Marciniak TA, Atar D, Serebruany V (2021)
    The perils of data sharing, meta-analyses, and estimating cardiovascular risk
    Eur Heart J Cardiovasc Pharmacother, 7 (3), e55-e57
    DOI 10.1093/ehjcvp/pvaa109, PubMed 32941601
31. Nguyen THP, Fagerland MW, Deyab G, Hjeltnes G, Hollan I, Feinberg MW, Eilertsen GØ, Mikkelsen K, Agewall S (2021)
    Antirheumatic therapy is not associated with changes in circulating N-terminal pro-brain natriuretic peptide levels in patients with autoimmune arthritis
    PLoS One, 16 (6), e0253793
    DOI 10.1371/journal.pone.0253793, PubMed 34170978
32. Oberprieler NG, Farahmand B, Cameron J, Brobert G, Jonasson C, Atar D (2021)
    Characteristics, treatment patterns, and residual cardiovascular risk of patients with a first acute myocardial infarction: A nationwide population-based cohort study in Norway
    Fundam Clin Pharmacol, 36 (3), 563-571
    DOI 10.1111/fcp.12744, PubMed 34904750
33. Peterson BE, Bhatt DL, Gabriel Steg P, Oldgren J, Maeng M, Zeymer U, Halvorsen S, Hohnloser SH, Lip GYH, Kimura T, Nordaby M, Miede C, Kleine E, Ten Berg JM, Cannon CP, RE-DUAL PCI Steering Committee and Investigators (2021)
    Evaluation of Dual Versus Triple Therapy by Landmark Analysis in the RE-DUAL PCI Trial
    JACC Cardiovasc Interv, 14 (7), 768-780
    DOI 10.1016/j.jcin.2021.02.022, PubMed 33826497
34. Pope MK, Atar D, Svilaas A, Hole T, Nielsen JD, Hintze U, Crisby M, Raatikainen P, Airaksinen KEJ, Virdone S, Pieper K, Kayani G, Le Heuzey JY, Steffel J, Stepinska J, Bassand JP, Camm AJ, GARFIELD-AF Investigators (2021)
    Risk profile, antithrombotic treatment and clinical outcomes of patients in Nordic countries with atrial fibrillation - results from the GARFIELD-AF registry
    Ann Med, 53 (1), 485-494
    DOI 10.1080/07853890.2021.1893897, PubMed 33818226
35. Pope MK, Hall TS, Schirripa V, Radic P, Virdone S, Pieper KS, Le Heuzey JY, Jansky P, Fitzmaurice DA, Cappato R, Atar D, Camm AJ, Kakkar AK, GARFIELD-AF investigators (2021)
    Cardioversion in patients with newly diagnosed non-valvular atrial fibrillation: observational study using prospectively collected registry data
    BMJ, 375, e066450
    DOI 10.1136/bmj-2021-066450, PubMed 34706884
36. Rubboli A, Atar D (2021)
    The debated issue of direct oral anticoagulants correct dosing: When even the reviewer is confused
    Eur J Intern Med, 90, 125-126
    DOI 10.1016/j.ejim.2021.05.009, PubMed 34090747
37. Rubboli A, Atar D (2021)
    Modulating the Intensity of Oral Anticoagulation Therapy with Direct Oral Anticoagulants: Feasible or Not?
    Am J Cardiovasc Drugs, 22 (2), 113-115
    DOI 10.1007/s40256-021-00488-4, PubMed 34254254
38. Rutherford OW, Jonasson C, Ghanima W, Söderdahl F, Halvorsen S (2021)
    Effectiveness and safety of oral anticoagulants in elderly patients with atrial fibrillation
    Heart, 108 (5), 345-352
    DOI 10.1136/heartjnl-2020-318753, PubMed 33975877
39. Rønning P, Helseth E, Skaansar O, Tverdal C, Andelic N, Bhatnagar R, Melberg M, Skaga NO, Aarhus M, Halvorsen S, Helseth R (2021)
    Impact of Preinjury Antithrombotic Therapy on 30-Day Mortality in Older Patients Hospitalized With Traumatic Brain Injury (TBI)
    Front Neurol, 12, 650695
    DOI 10.3389/fneur.2021.650695, PubMed 34054695
40. Sandberg EL, Grenne BL, Berge T, Grimsmo J, Atar D, Halvorsen S, Fensli R, Jortveit J (2021)
    Diagnostic Accuracy and Usability of the ECG247 Smart Heart Sensor Compared to Conventional Holter Technology
    J Healthc Eng, 2021, 5230947
    DOI 10.1155/2021/5230947, PubMed 34765102
41. Schiele F, Aktaa S, Rossello X, Ahrens I, Claeys MJ, Collet JP, Fox KAA, Gale CP, Huber K, Iakobishvili Z, Keys A, Lambrinou E, Leonardi S, Lettino M, Masoudi FA, Price S, Quinn T, Swahn E, Thiele H, Timmis A, Tubaro M, Vrints CJM, Walker D, Bueno H, ESC Scientific Document Group et al. (2021)
    2020 Update of the quality indicators for acute myocardial infarction: a position paper of the Association for Acute Cardiovascular Care: the study group for quality indicators from the ACVC and the NSTE-ACS guideline group
    Eur Heart J Acute Cardiovasc Care, 10 (2), 224-233
    DOI 10.1093/ehjacc/zuaa037, PubMed 33550362
42. Svenungsson E, Spaak J, Strandberg K, Wallén HN, Agewall S, Brolin EB, Collste O, Daniel M, Ekenbäck C, Frick M, Henareh L, Malmqvist K, Elvin K, Sörensson P, Y-Hassan S, Hofman-Bang C, Tornvall P (2021)
    Antiphospholipid antibodies in patients with myocardial infarction with and without obstructive coronary arteries
    J Intern Med, 291 (3), 327-337
    DOI 10.1111/joim.13409, PubMed 34820922
43. Taegtmeyer H, Atar D (2021)
    Icons in Cardiology
    Cardiology, 146 (6), 667
    DOI 10.1159/000519019, PubMed 34412055
44. Täger T, Atar D, Agewall S, Katus HA, Grundtvig M, Cleland JGF, Clark AL, Fröhlich H, Frankenstein L (2021)
    Comparative efficacy of sodium-glucose cotransporter-2 inhibitors (SGLT2i) for cardiovascular outcomes in type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials
    Heart Fail Rev, 26 (6), 1421-1435
    DOI 10.1007/s10741-020-09954-8, PubMed 32314085
45. Täger T, Frankenstein L, Atar D, Agewall S, Frey N, Grundtvig M, Clark AL, Cleland JGF, Fröhlich H (2021)
    Influence of receptor selectivity on benefits from SGLT2 inhibitors in patients with heart failure: a systematic review and head-to-head comparative efficacy network meta-analysis
    Clin Res Cardiol, 111 (4), 428-439
    DOI 10.1007/s00392-021-01913-z, PubMed 34498169
46. Tøllefsen IM, Shetelig C, Seljeflot I, Eritsland J, Hoffmann P, Andersen GØ (2021)
    High levels of interleukin-6 are associated with final infarct size and adverse clinical events in patients with STEMI
    Open Heart, 8 (2)
    DOI 10.1136/openhrt-2021-001869, PubMed 34933964
47. Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, Benetos A, Biffi A, Boavida JM, Capodanno D, Cosyns B, Crawford C, Davos CH, Desormais I, Di Angelantonio E, Franco OH, Halvorsen S, Hobbs FDR, Hollander M, Jankowska EA, Michal M, Sacco S, Sattar N, Tokgozoglu L, Tonstad S et al. (2021)
    2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
    Eur Heart J, 42 (34), 3227-3337
    DOI 10.1093/eurheartj/ehab484, PubMed 34458905

Publications 2020

1. Agewall S (2020)
   Focus on pharma in acute coronary syndrome
   Eur Heart J Cardiovasc Pharmacother, 6 (1), 1-2
   DOI 10.1093/ehjcvp/pvz074, PubMed 31909430
2. Agewall S (2020)
   Lipids and antithrombotic treatment
   Eur Heart J Cardiovasc Pharmacother, 6 (2), 71
   DOI 10.1093/ehjcvp/pvaa014, PubMed 32176294
3. Agewall S (2020)
   Focus on subpopulations of atrial fibrillation patients
   Eur Heart J Cardiovasc Pharmacother, 6 (3), 131-132
   DOI 10.1093/ehjcvp/pvaa034, PubMed 32412082
4. Agewall S (2020)
   Can we offer tailor-made pharmacological treatment of patients with acute coronary syndrome?
   Eur Heart J Cardiovasc Pharmacother, 6 (4), 201-202
   DOI 10.1093/ehjcvp/pvaa075, PubMed 32668002
5. Agewall S (2020)
   Minimizing bleeding events
   Eur Heart J Cardiovasc Pharmacother, 6 (5), 271-272
   DOI 10.1093/ehjcvp/pvaa100, PubMed 32932523
6. Agewall S (2020)
   Focus on blood pressure and risk factor intervention
   Eur Heart J Cardiovasc Pharmacother, 6 (6), 339-340
   DOI 10.1093/ehjcvp/pvaa130, PubMed 33197927
7. Atar D, Berge E, Le Heuzey JY, Virdone S, Camm AJ, Steffel J, Gibbs H, Goldhaber SZ, Goto S, Kayani G, Misselwitz F, Stepinska J, Turpie AGG, Bassand JP, Kakkar AK, GARFIELD-AF Investigators (2020)
   The association between patterns of atrial fibrillation, anticoagulation, and cardiovascular events
   Europace, 22 (2), 195-204
   DOI 10.1093/europace/euz292, PubMed 31747004
8. Bassand JP, Apenteng PN, Atar D, Camm AJ, Cools F, Corbalan R, Fitzmaurice DA, Fox KA, Goto S, Haas S, Hacke W, Jerjes-Sanchez C, Koretsune Y, Heuzey JL, Sawhney JP, Oh S, Stępińska J, Cate VT, Verheugt FW, Kayani G, Pieper KS, Kakkar AK, Garfield-Af Investigators FT (2020)
   GARFIELD-AF: a worldwide prospective registry of patients with atrial fibrillation at risk of stroke
   Future Cardiol, 17 (1), 19-38
   DOI 10.2217/fca-2020-0014, PubMed 32696663
9. Birnbaum Y, Levine GN, French J, Kaski JC, Atar D, Alam M, Hasdai D, Jneid H, Uretsky BF (2020)
   Inferior ST-Elevation Myocardial Infarction Presenting When Urgent Primary Percutaneous Coronary Intervention Is Unavailable: Should We Adhere to Current Guidelines?
   Cardiovasc Drugs Ther, 34 (6), 865-870
   DOI 10.1007/s10557-020-07039-0, PubMed 32671603
10. Bittner VA, Szarek M, Aylward PE, Bhatt DL, Diaz R, Edelberg JM, Fras Z, Goodman SG, Halvorsen S, Hanotin C, Harrington RA, Jukema JW, Loizeau V, Moriarty PM, Moryusef A, Pordy R, Roe MT, Sinnaeve P, Tsimikas S, Vogel R, White HD, Zahger D, Zeiher AM, Steg PG, Schwartz GG et al. (2020)
    Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome
    J Am Coll Cardiol, 75 (2), 133-144
    DOI 10.1016/j.jacc.2019.10.057, PubMed 31948641
11. Blichfeldt-Ærø SC, Knutsen TM, Hagen HM, Diep LM, Trondalen G, Halvorsen S (2020)
    Music therapy as an adjunct in cardiac device lead extraction procedures: A randomized controlled trial
    Appl Nurs Res, 56, 151376
    DOI 10.1016/j.apnr.2020.151376, PubMed 33280783
12. Bogsrud MP, Øyri LKL, Halvorsen S, Atar D, Leren TP, Holven KB (2020)
    Prevalence of genetically verified familial hypercholesterolemia among young (<45 years) Norwegian patients hospitalized with acute myocardial infarction
    J Clin Lipidol, 14 (3), 339-345
    DOI 10.1016/j.jacl.2020.04.002, PubMed 32418822
13. Broberg AM, Geisler J, Tuohinen S, Skytta T, Hrafnkelsdóttir ÞJ, Nielsen KM, Hedayati E, Omland T, Offersen BV, Lyon AR, Gulati G (2020)
    Prevention, Detection, and Management of Heart Failure in Patients Treated for Breast Cancer
    Curr Heart Fail Rep, 17 (6), 397-408
    DOI 10.1007/s11897-020-00486-8, PubMed 32979150
14. Broberg AM, Tuohinen S, Skytta T, Geisler J, Hrafnkelsdóttir ÞJ, Smáradóttir A, Nielsen KM, Offersen BV, Jarfelt M, Gulati G (2020)
    The Establishment of the Nordic Cardio-Oncology Society
    JACC CardioOncol, 2 (2), 333-335
    DOI 10.1016/j.jaccao.2020.04.004, PubMed 34396242
15. Butt N, Bache-Mathiesen LK, Ushakova A, Nordrehaug JE, Jensen SE, Munk PS, Danchin N, Dubois-Rande JL, Hansen HS, Paganelli F, Corvoisier PL, Firat H, Erlinge D, Atar D, Larsen AI (2020)
    Pentraxin 3 in primary percutaneous coronary intervention for ST elevation myocardial infarction is associated with early irreversible myocardial damage : Kinetic profile, relationship to interleukin 6 and infarct size
    Eur Heart J Acute Cardiovasc Care, 9 (4), 302-312
    DOI 10.1177/2048872620923641, PubMed 32403934
16. Chieffo A, Stefanini GG, Price S, Barbato E, Tarantini G, Karam N, Moreno R, Buchanan GL, Gilard M, Halvorsen S, Huber K, James S, Neumann FJ, Möllmann H, Roffi M, Tavazzi G, Ferré JM, Windecker S, Dudek D, Baumbach A (2020)
    EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemic
    EuroIntervention, 16 (3), 233-246
    DOI 10.4244/EIJY20M05_01, PubMed 32404302
17. Chieffo A, Stefanini GG, Price S, Barbato E, Tarantini G, Karam N, Moreno R, Buchanan GL, Gilard M, Halvorsen S, Huber K, James S, Neumann FJ, Möllmann H, Roffi M, Tavazzi G, Mauri Ferré J, Windecker S, Dudek D, Baumbach A (2020)
    EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemic
    Eur Heart J, 41 (19), 1839-1851
    DOI 10.1093/eurheartj/ehaa381, PubMed 32405641
18. Cramariuc D, Bahlmann E, Egstrup K, Rossebø AB, Ray S, Kesäniemi YA, Nienaber CA, Gerdts E (2020)
    Prognostic impact of impaired left ventricular midwall function during progression of aortic stenosis
    Echocardiography, 38 (1), 31-38
    DOI 10.1111/echo.14916, PubMed 33146452
19. Drexel H, Rosano GMC, Lewis BS, Huber K, Vonbank A, Dopheide JF, Mader A, Niessner A, Savarese G, Wassmann S, Agewall S (2020)
    The age of randomized clinical trials: three important aspects of randomized clinical trials in cardiovascular pharmacotherapy with examples from lipid and diabetes trials
    Eur Heart J Cardiovasc Pharmacother, 6 (2), 97-103
    DOI 10.1093/ehjcvp/pvz029, PubMed 31298686
20. Frankenstein L, Seide S, Täger T, Jensen K, Fröhlich H, Clark AL, Seiz M, Katus HA, Nee P, Uhlmann L, Naci H, Atar D (2020)
    Relative Efficacy of Spironolactone, Eplerenone, and cAnRenone in patients with Chronic Heart failure (RESEARCH): a systematic review and network meta-analysis of randomized controlled trials
    Heart Fail Rev, 25 (2), 161-171
    DOI 10.1007/s10741-019-09832-y, PubMed 31364027
21. Ghanima W, Brodin E, Schultze A, Shepherd L, Lambrelli D, Ulvestad M, Ramagopalan S, Halvorsen S (2020)
    Incidence and prevalence of venous thromboembolism in Norway 2010-2017
    Thromb Res, 195, 165-168
    DOI 10.1016/j.thromres.2020.07.011, PubMed 32707359
22. Gorenek B, Halvorsen S, Kudaiberdieva G, Bueno H, Van Gelder IC, Lettino M, Marin F, Masip J, Mueller C, Okutucu S, Poess J, Potpara TS, Price S, Lip GYH (2020)
    Atrial fibrillation in acute heart failure: A position statement from the Acute Cardiovascular Care Association and European Heart Rhythm Association of the European Society of Cardiology
    Eur Heart J Acute Cardiovasc Care, 9 (4), 348-357
    DOI 10.1177/2048872619894255, PubMed 31976747
23. Hollan I, Ronda N, Dessein P, Agewall S, Karpouzas G, Tamargo J, Niessner A, Savarese G, Rosano G, Kaski JC, Wassmann S, Meroni PL (2020)
    Lipid management in rheumatoid arthritis: a position paper of the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology
    Eur Heart J Cardiovasc Pharmacother, 6 (2), 104-114
    DOI 10.1093/ehjcvp/pvz033, PubMed 31397840
24. Johannessen TR, Vallersnes OM, Halvorsen S, Larstorp ACK, Mdala I, Atar D (2020)
    Pre-hospital One-Hour Troponin in a Low-Prevalence Population of Acute Coronary Syndrome: OUT-ACS study
    Open Heart, 7 (2)
    DOI 10.1136/openhrt-2020-001296, PubMed 32719074
25. Jortveit J, Halvorsen S, Langørgen J (2020)
    Pharmacy-dispensed drugs for secondary prevention after myocardial infarction
    Tidsskr Nor Laegeforen, 140 (4)
    DOI 10.4045/tidsskr.19.0416, PubMed 32192264
26. Jortveit J, Pripp AH, Langørgen J, Halvorsen S (2020)
    Incidence, risk factors and outcome of young patients with myocardial infarction
    Heart, 106 (18), 1420-1426
    DOI 10.1136/heartjnl-2019-316067, PubMed 32111640
27. Khatami M, Pope MK, Le Page S, Radic P, Schirripa V, Grundvold I, Atar D (2020)
    Cardioversion Safety - Are We Doing Enough?
    Cardiology, 145 (11), 740-745
    DOI 10.1159/000509343, PubMed 32898849
28. Kjeldsen SE, Halvorsen S, Wyller TB, Bath PM, Sandercock P (2020)
    Eivind Berge, MD, PhD, 1964-2020: Cardiologist Who Was Fighting Stroke
    Stroke, 51 (5), 1353-1355
    DOI 10.1161/STROKEAHA.120.029351, PubMed 32200755
29. Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, Prescott E, Storey RF, Deaton C, Cuisset T, Agewall S, Dickstein K, Edvardsen T, Escaned J, Gersh BJ, Svitil P, Gilard M, Hasdai D, Hatala R, Mahfoud F, Masip J, Muneretto C, Valgimigli M, Achenbach S, Bax JJ et al. (2020)
    2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes
    Eur Heart J, 41 (3), 407-477
    DOI 10.1093/eurheartj/ehz425, PubMed 31504439
30. Krogstad V, Peric A, Robertsen I, Kringen MK, Vistnes M, Hjelmesæth J, Sandbu R, Johnson LK, Angeles PC, Jansson-Löfmark R, Karlsson C, Andersson S, Åsberg A, Andersson TB, Christensen H (2020)
    Correlation of Body Weight and Composition With Hepatic Activities of Cytochrome P450 Enzymes
    J Pharm Sci, 110 (1), 432-437
    DOI 10.1016/j.xphs.2020.10.027, PubMed 33091408
31. Langseth MS, Helseth R, Ritschel V, Hansen CH, Andersen GØ, Eritsland J, Halvorsen S, Fagerland MW, Solheim S, Arnesen H, Seljeflot I, Opstad TB (2020)
    Double-Stranded DNA and NETs Components in Relation to Clinical Outcome After ST-Elevation Myocardial Infarction
    Sci Rep, 10 (1), 5007
    DOI 10.1038/s41598-020-61971-7, PubMed 32193509
32. Pope MK, Ghanima W, Atar D (2020)
    Intensification of antithrombotic therapy for chronic atherosclerosis
    Tidsskr. Nor. Laegeforen., 140 (10), 976-977
33. Pope MK, Ghanima W, Atar D (2020)
    Intensification of antithrombotic therapy for chronic atherosclerosis
    Tidsskr Nor Laegeforen, 140 (10)
    DOI 10.4045/tidsskr.20.0066, PubMed 32602309
34. Rutherford OW, Jonasson C, Ghanima W, Söderdahl F, Halvorsen S (2020)
    Comparison of dabigatran, rivaroxaban, and apixaban for effectiveness and safety in atrial fibrillation: a nationwide cohort study
    Eur Heart J Cardiovasc Pharmacother, 6 (2), 75-85
    DOI 10.1093/ehjcvp/pvz086, PubMed 31942972
35. Savarese G, Reiner MF, Uijl A, D'Amario D, Agewall S, Atar D, Baumgartner I, Borghi C, De Carlo M, Drexel H, Kaski JC, Kjeldsen KP, Kucher N, Lund LH, Niessner A, Semb AG, Schmidt TA, Sulzgruber P, Tamargo J, Vitale C, Wassmann S, Aboyans V, Lewis BS (2020)
    Antithrombotic therapy and major adverse limb events in patients with chronic lower extremity arterial disease: systematic review and meta-analysis from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy in Collaboration with the European Society of Cardiology Working Group on Aorta and Peripheral Vascular Diseases
    Eur Heart J Cardiovasc Pharmacother, 6 (2), 86-93
    DOI 10.1093/ehjcvp/pvz036, PubMed 31392312
36. Sinning C, Ahrens I, Cariou A, Beygui F, Lamhaut L, Halvorsen S, Nikolaou N, Nolan JP, Price S, Monsieurs K, Behringer W, Cecconi M, Van Belle E, Jouven X, Hassager C (2020)
    The cardiac arrest centre for the treatment of sudden cardiac arrest due to presumed cardiac cause - aims, function and structure: Position paper of the Association for Acute CardioVascular Care of the European Society of Cardiology (AVCV), European Association of Percutaneous Coronary Interventions (EAPCI), European Heart Rhythm Association (EHRA), European Resuscitation Council (ERC), European Society for Emergency Medicine (EUSEM) and European Society of Intensive Care Medicine (ESICM)
    Eur Heart J Acute Cardiovasc Care, 9 (4_suppl), S193-S202
    DOI 10.1177/2048872620963492, PubMed 33327761
37. Stensjøen AL, Hommerstad A, Halvorsen S, Arheden H, Engblom H, Erlinge D, Larsen AI, Sejersten Ripa M, Clemmensen P, Atar D, Hall TS (2020)
    Worst lead ST deviation and resolution of ST elevation at one hour for prediction of myocardial salvage, infarct size, and microvascular obstruction in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention
    Ann Noninvasive Electrocardiol, 25 (6), e12784
    DOI 10.1111/anec.12784, PubMed 32592427
38. Stepinska J, Lettino M, Ahrens I, Bueno H, Garcia-Castrillo L, Khoury A, Lancellotti P, Mueller C, Muenzel T, Oleksiak A, Petrino R, Guimenez MR, Zahger D, Vrints CJ, Halvorsen S, de Maria E, Lip GY, Rossini R, Claeys M, Huber K (2020)
    Diagnosis and risk stratification of chest pain patients in the emergency department: focus on acute coronary syndromes. A position paper of the Acute Cardiovascular Care Association
    Eur Heart J Acute Cardiovasc Care, 9 (1), 76-89
    DOI 10.1177/2048872619885346, PubMed 31958018
39. Szarek M, Bittner VA, Aylward P, Baccara-Dinet M, Bhatt DL, Diaz R, Fras Z, Goodman SG, Halvorsen S, Harrington RA, Jukema JW, Moriarty PM, Pordy R, Ray KK, Sinnaeve P, Tsimikas S, Vogel R, White HD, Zahger D, Zeiher AM, Steg PG, Schwartz GG, ODYSSEY OUTCOMES Investigators (2020)
    Lipoprotein(a) lowering by alirocumab reduces the total burden of cardiovascular events independent of low-density lipoprotein cholesterol lowering: ODYSSEY OUTCOMES trial
    Eur Heart J, 41 (44), 4245-4255
    DOI 10.1093/eurheartj/ehaa649, PubMed 33051646
40. Tancin Lambert A, Kong XY, Ratajczak-Tretel B, Atar D, Russell D, Skjelland M, Bjerkeli V, Skagen K, Coq M, Schordan E, Firat H, Halvorsen B, Aamodt AH (2020)
    Biomarkers Associated with Atrial Fibrillation in Patients with Ischemic Stroke: A Pilot Study from the NOR-FIB Study
    Cerebrovasc Dis Extra, 10 (1), 11-20
    DOI 10.1159/000504529, PubMed 32028277
41. Willeit P, Tschiderer L, Allara E, Reuber K, Seekircher L, Gao L, Liao X, Lonn E, Gerstein HC, Yusuf S, Brouwers FP, Asselbergs FW, van Gilst W, Anderssen SA, Grobbee DE, Kastelein JJP, Visseren FLJ, Ntaios G, Hatzitolios AI, Savopoulos C, Nieuwkerk PT, Stroes E, Walters M, Higgins P, Dawson J et al. (2020)
    Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk: Meta-Analysis of 119 Clinical Trials Involving 100 667 Patients
    Circulation, 142 (7), 621-642
    DOI 10.1161/CIRCULATIONAHA.120.046361, PubMed 32546049
42. Wyller TB, Kjeldsen SE, Halvorsen S, Bath PM, Sandercock P (2020)
    In memoriam Eivind Berge, MD, PhD, 1964-2020: cardiologist, trialist and hypertension/stroke researcher
    J. Hypertens., 38 (6), 1199-1200
    DOI 10.1097/HJH.0000000000002488
43. Zamorano JL, Gottfridsson C, Asteggiano R, Atar D, Badimon L, Bax JJ, Cardinale D, Cardone A, Feijen EAM, Ferdinandy P, López-Fernández T, Gale CP, Maduro JH, Moslehi J, Omland T, Plana Gomez JC, Scott J, Suter TM, Minotti G (2020)
    The cancer patient and cardiology
    Eur J Heart Fail, 22 (12), 2290-2309
    DOI 10.1002/ejhf.1985, PubMed 32809231
44. Ødegaard KM, Hallén J, Lirhus SS, Melberg HO, Halvorsen S (2020)
    Incidence, prevalence, and mortality of heart failure: a nationwide registry study from 2013 to 2016
    ESC Heart Fail, 7 (4), 1917-1926
    DOI 10.1002/ehf2.12773, PubMed 32530563
45. Aamodt AH, Bjork MH, Tronvik EA, Buanes EA, Stovner LJ, Atar D (2020)
    Do ACE inhibitors and angiotensin receptor antagonists increase the risk of severe Covid-19?
    Tidsskr. Nor. Laegeforen., 140 (9), 859-860
46. Aamodt IT, Lycholip E, Celutkiene J, von Lueder T, Atar D, Falk RS, Hellesø R, Jaarsma T, Strömberg A, Lie I (2020)
    Self-Care Monitoring of Heart Failure Symptoms and Lung Impedance at Home Following Hospital Discharge: Longitudinal Study
    J Med Internet Res, 22 (1), e15445
    DOI 10.2196/15445, PubMed 31909717